Zdeněk Pospíšil - cited publications

DOUBKOVÁ, M., POSPÍŠIL, Z., SKŘIČKOVÁ, J., DOUBEK, M. Prognostic markers of sarcoidosis: An analysis of patients from everyday pneumological practice. Clinical Respiratory Journal 2015, vol. 9, p. 443-449.

CASTRO, M.D.C., de CASTRO PEREIRA, C.A., SOARES, M.R. Prognostic features of sarcoidosis course in a Brazilian cohort. J Bras Pneumol 2022, vol. 48, no. 1, e20210366, DOI: 10.36416/1806-3756/e20210366
CAMELI, P., CAFFARELLI, C., REFINI, R.M., BERGANTINI, L., ALESSANDRO, M., ARMATI, M., PITINCA, M.D., SESTINI, P., GONNELLI, S., BARGAGLI, E. Hypercalciuria in sarcoidosis: A specific biomarker with clinical utility. Frontiers in Medicine 2020, vol. 7, Art. no. 568020.
SILVA, A.L., MELO, P., MOTA, P.C., LIMA, B., PEREIRA, J.M., CUNHA, R., GUIMARAES, S., SOUTO-MOURA, C., MORAIS, A. Pulmonary Sarcoidosis: Prognostic Factors at Diagnosis in Patients from North of Portugal. Reumatología Clínica 2020, vol. 16, no. 6, p.468-472. doi: 10.1016/j.reuma.2018.10.004
CUNHA CASTRO, M.D., PEREIRA, C.A.C. Nonlife-Threatening Sarcoidosis. Semin Respir Crit Care Med. 2020, vol. 41, no. 5, p. 733-740. doi: 10.1055/s-0040-1710371.
FANG, C.L., ZHANG, Q., WANG, N., JING, X.Y., XU, Z.J. Effectiveness and tolerability of methotrexate in pulmonary sarcoidosis: A single center real-world study. Sarcoidosis Vasculitis and Diffuse Lung Diseases 2019, vol. 36, no. 3, p. 217-227.
KARAKAYA, B., SCHIMMELPENNINK, M.C., KOCOURKOVÁ, L., VAN DER VIS, J.J., MEEK, B., GRUTTERS, J.C., PETREK, M., VAN MOORSEL, C.H.M. Bronchoalveolar lavage characteristics correlate with HLA tag SNPs in patients with Lofgren's syndrome and other sarcoidosis. Clinical and Experimental Immunology 2019, vol. 196, no. 2, p.249-258.
SCHIMMELPENNINK, M.C., VORSELAARS, A.D.M., GRUTTERS, J.C. Biomarkers in Sarcoidosis. Sarcoidosis 2019, p. 219-238, doi: 10.1016/B978-0-323-54429-0.00019-7
RAMOS-CASALS, M., RETAMOZO, S., SISO-ALMIRALL, A., PEREZ-ALVAREZ, R., PALLARES, L., BRITO-ZERON, P. Clinically-useful serum biomarkers for diagnosis and prognosis of sarcoidosis. Expert Review of Clinical Immunology 2019, vol. 15, no. 4, p. 391-405.
VYŠEHRADSKÝ, R., PAÁLOVÁ, I., KOCAN, I., SLOVÁKOVÁ, D. Faktory ovplyvňujúce senzitívnost' pomeru CD4+/CD8+ lymfocytov v bronchoalveolárnej lavážovej tekutine pacientov so sarkoidózou. Studia Pneumologica et Phthiseologica 2016, vol. 76, no. 5, p. 168--174.
PEREIRA, C.A.C., DORNFELD, M.C., BAUGHAM, R., JUDSON, M.A. Clinical phenotypes in sarcoidosis. Current Opinion in Pulmonary Medicine 2014, vol. 20, no. 5, p. 496-502.

SIKOROVA, K., OSOEGAWA, K., KOCOURKOVÁ, L., STRNAD, A., PETRKOVÁ, J., FERNANDEZ-VINA, M.A., DOUBKOVÁ, M., PETREK, M. Association between sarcoidosis and HLA polymorphisms in a Czech population from Central Europe: focus on a relationship with clinical outcome and treatment. Frontiers in Medicine 2023, vol. 10, art. no. 1094843
ŠTEFÁNIKOVÁ, M., DOUBKOVÁ, M. Epidemiology of interstitial lung diseases. Studia Pneumologica et Phthiseologica 2019, vol. 79, no. 3, p. 96-103.

back

WEINBERGEROVÁ, B., MAYER, J., HRABOVSKÝ, Š., NOVÁKOVÁ, Z., POSPÍŠIL, Z., MARTYKANOVÁ, L., HORTOVA, K., MANDELOVÁ, L., HEJDUK, K., CHLOUPKOVÁ, R., POSPÍŠIL, M., DOUBKOVÁ, M., MAREK, V., NOVOTNÁ, R., DOLEČEK, M., MATĚJOVSKÁ KUBEŠOVÁ, H., BRAT, K., PAŘÍZKOVÁ, R., HUSA, P., MECHL, M., KRÁL, Z., LENGEROVÁ, M. COVID-19's natural course among ambulatory monitored outpatients. Scientific Reports 2021, vol. 11, art. no. 10124.

BIRD, O., GALIZA, E.P., BAXTER, D.N., BOFFITO, M., BROWNE, D., BURNS, F., CHADWICK, D.R., CLARK, R., COSGROVE, C.A., GALLOWAY, J., GOODMAN, A.L., HEER, A., HIGHAM, A., IYENGAR, S., JEANES, C., KALRA, P.A., KYRIAKIDOU, C., BRADLEY, J.M., MUNTHALI, C., MINASSIAN, A.M., McGILL, F., MOORE, P., MUNSOOR, I., NICHOLLS, H., OSANLOU, O., PACKHAM, J., PRETSWELL, C.H., RAMOS, A.SF., SARALAYA, D., SHERIDAN, R.P., SMITH, R., SOIZA, R.L., A SWIFT, P.A., THOMSON, E.C., TURNER,J., VILJOEN, M.E., HEATH, P.T., STER, I.C. The Predictive Role of Symptoms in COVID-19 Diagnostic Models - A Longitudinal Insight. Epidemiol Infect 2024, DOI: 10.1017/S0950268824000037 Online ahead of print
TSHABANE, C., KUONZA, L., MDOSE, H., MUSEKIWA, A.,MOTAZE, N.V. Estimation of shedding time in laboratory-confirmed COVID-19 cases in South Africa: a population-based record linkage study, March-December 2020. Pan African Medical Journal 2023, vol. 46, art. no. 24, DOI: 10.11604/pamj.2023.46.24.41047.
LINOS, C., PETELOS, E., LINARDAKIS, M., DIAMANTAKIS, A., SYMVOULAKIS, E., KARKANA, M.-N., KAMPA, M., PIRINTSOS, S., SOURVINOS, G., CASTANAS, E. A Mixture of Essential Oils from Three Cretan Aromatic Plants Inhibits SARS-CoV-2 Proliferation: A Proof-of-Concept Intervention Study in Ambulatory Patients. Diseases 2023, vol. 11, no. 3, DOI: 10.3390/diseases11030105.
BUITRAGO-GARCIA, D., MERT, I.A., HERON, L., IMERI, H., ARAUJO-CHAVERON, L., AREVALO-RODRIGUEZ, I., CIAPPONI, A., CEVIK, M., HAUSER, A., IRFANUL, A.,M., MEILI, K., MEYEROWITZ, E.A., PRAJAPATI, N., QIU, X., RICHTERMAN, A., ROBLES-RODRIGUEZ, W.G., THAPA, S., ZHELYAZKOV, I., SALANTI, G., LOW, N. Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: Update of a living systematic review and meta-analysis. PLoS Med. 2022, vol. 19, no. 5, e1003987, DOI: 10.1371/journal.pmed.1003987.
FINSTER, J., SCORZA, F.A. Exclude differentials before attributing post-COVID fatigue to myopathy. Clinical Neurophysiology 2021, vol. 132, no. 9, p. 2324-2325, DOI: 10.1016/j.clinph.2021.06.018.

back

WEINBERGEROVÁ, B., KABUT, T., KOCMANOVÁ, I., LENGEROVÁ M., POSPÍŠIL, Z., KRÁL, Z., MAYER, J. Bronchoalveolar lavage fluid and serum 1,3-β-d-glucan testing for invasive pulmonary aspergillosis diagnosis in hematological patients: the role of factors affecting assay performance. Scientific Reports 2020, vol. 10, art. no. 17963.

SCHARMANN, U., VERHASSELT, H.L., KIRCHHOFF, L., FURNICA, D.-T., STEINMANN, J., RATH, P.-M. Microbiological Non-Culture-Based Methods for Diagnosing Invasive Pulmonary Aspergillosis in ICU Patients. Diagnostics 2023, vol. 13, no. 16 doi: 10.3390/diagnostics13162718
DOBIÁŠ, R., STEVENS, D.A., HAVLÍČEK, V. Current and Future Pathways in Aspergillus Diagnosis. Antibiotics 2023, vol. 12, no. 2, doi: 10.3390/antibiotics12020385
CHENG, Z., WEI, W., WU, C., ZHU, C., WANG, Z., HUANG, Y., XIA, H. Diagnostic value of galactomannan detection in bronchoalveolar lavage fluid in COVID-19 associated invasive pulmonary fungal infection. Chinese Journal of Clinical Research 2023, vol. 36, no. 9, p. 1366-1369. doi: 10.13429/j.cnki.cjcr.2023.09.018
HAMMARSTRÖM, H., MAGNUSSON, J., STJÄRNE ASPELUND, A., STENMARK, J., ISAKSSON, J., KONDORI, N., RIISE, G.C., WENNERÅS, C., FRIMAN, V. Fungal Tracheobronchitis in Lung Transplant Recipients: Incidence and Utility of Diagnostic Markers. Fungi 2023, vol. 9, no. 1, doi: 10.3390/jof9010003
SIOPI, M., KARAKATSANIS, S., ROUMPAKIS, C., KORANTANIS, K., ELDEIK, E., SAMBATAKOU, H., SIPSAS, N.V., PAGONI, M, STAMOULI, M., TSIRIGOTIS, P., MELETIADIS, J. Evaluation of the Dynamiker® Fungus (1-3)-ß-d-Glucan Assay for the Diagnosis of Invasive Aspergillosis in High-Risk Patients with Hematologic Malignancies. Infectious Diseases and Therapy 2022, vol. 11, p. 1161-1175, doi: 10.1007/s40121-022-00627-7
DOUGLAS, A.P., SMIBERT, O.C., BAJEL, A., HALLIDAY, C.L., LAVEE, O., McMULLAN, B., YONG, M.K., van HAL, S.J., CHEN, S.C-A. Consensus guidelines for the diagnosis and management of invasive aspergillosis, 2021. International Medicine Journal 2021, vol. 51, no. S7, p. 143-176 doi: 10.1111/imj.15591

back

KAŠE, V., HAMPEJS, T., POSPÍŠIL, Z. Modeling Cultural Transmission of Rituals in Silico: The Advantages and Pitfalls of Agent-Based vs. System Dynamics Models. Journal of Cognition and Culture 2018, vol. 18, no. 5, pp. 483-507.

LANG, M., CHVAJA, R. HAZARD PRECAUTION: Examining the Possible Adaptive Value of Ritualized Behavior. Book Chapter in LIOR, Y., LANE, J. The Routlege Handbook of Evolutionary Approaches to Religion. Taylor&Francis, London 2022, p. 164-184, ISBN 978-100063838-7, 978-113833167-9
LANGE, R., HOURAN, J., SHERIDAN, L., DAGNALL, N., DRINKWATER, K., O'KEEFFE, C., LAYTHE, B. Haunted people syndrome revisited: empirical parallels between subjective paranormal episodes and group-stalking accounts. Mental Health Religion & Culture 2020, doi: 10.1080/13674676.2020.1767552
LANG, M., KUNDT, R. Evolutionary, Cognitive, and Contextual Approaches to the Study of Religious Systems: A Proposition of Synthesis. Method and Theory in the Study of Religion. 2020, vol. 32, no. 1, pp. 1-46.
DIALLO, S.Y. Five things to know about modeling and simulation. Archive for the Psychology of Religion 2019, vol. 41, no. 2, pp. 172-185.

back

GLOMB, T., MERTEL, A., POSPÍŠIL, Z.,CHALUPA, A. Ptolemaic political activities on the west coast of Hellenistic Asia Minor had a significant impact on the local spread of the Isiac cults: A spatial network analysis. PLoS ONE 2020, vol. 15, no. 4, e0230733

MATSUMOTO, M.E. Archaeology and Epigraphy in the Digital Era. Journal of Archeological Research 2021, DOI: 10.1007/s10814-021-09162-4

GLOMB, T., KAŠE, V., HEŘMÁNKOVÁ, P. Popularity of the cult of Asclepius in the times of the Antonine Plague: Temporal modeling of epigraphic evidence. Journal of Archeological Science-Reports 2022, Vol. 43, Art.No. 103466, DOI: 10.1016/j.jasrep.2022.103466
GLOMB, T. The spread of the cult of Asclepius in the context of the Roman army benefited from the presence of physicians: A spatial proximity analysis. PLoS ONE 2021, vol. 16, no. 8, art.no. e0256356.

back

GLOMB, T., MERTEL, A., POSPÍŠIL, Z., STACHOŇ, Z., CHALUPA, A. Ptolemaic military operations were a dominant factor in the spread of Egyptian cults across the early Hellenistic Aegean Sea. PLoS ONE 2018, vol. 13, no. 3, e0193786.

SIEGAL, M.B-A., YOVEL, Y. Network analysis reveals insights about the interconnections of Judaism and Christianity in the first centuries CE. Humanities & Social Sciences Communications 2023, vol. 10, no. 1, art.`no. 191, doi: 10.1057/s41599-023-01678-y
NEUMANN, S. Spatializing `Divine Newcomers' in Athens. in GALOPPIN, T., GUILLON, E., LUACES, M., LÄTZER-LASAR, A., LEBRETON,S., PORZIA,F., RÜPKE, J, RUBENS URCIUOLI, E., BONNET, C. (eds.) Naming and Mapping the Gods in the Ancient Mediterranean. Spaces, Mobilities, Imaginaries, De Gruyter, 2022, p. 825-852, ISBN 978-311079843-2, 978-311079649-0, doi: 10.1515/9783110798432-043
BLAKELY, S., MUNDY, J. Strong ties and deep habits: The Samothracian diaspora in network perspective. in COLLAR, A. (ed.) Networks and the Spread of Ideas in the Past: Strong Ties, innovation and Knowledge Exchange, Taylor and Francis, 2022, p. 99-136, ISBN 978-042976931-3, 978-113836847-7, doi: 10.4324/9780429429217-5
CZACHESZ, I. Network Science in Biblical Studies: Introduction. Annali di Storia dell'Esegesi 2022, vol. 39, no. 1, pp. 9-26.
THALES, S. Complexity theory and the historical study of religion navigating the transdisciplinary space between the Humanities and the Natural Sciences. História da Historiagrafia 2021, vol.14, no.36, doi: 10.15848/hh.v14i36.1669
LANE, J. Understanding Religion Through Artificial Intelligence. Bonding and Belief. New York: Bloomsbury Academic, 2021, ISBN 9781350103566
BRICAULT, L. Isis Pelagia: Images, Names and Cults of a Goddess of the Seas. Leiden: Koninklije Brill NV, 2019, ISBN 978-90-04-41389-4.
KOĽVEKOVÁ, G., PALAŠČÁKOVÁ, D. A Country Benefits Related to Education Sector Using the Data for Input-Output Analysis. ICETA 2018 - 16th IEEE International Conference on Emerging eLearning Technologies and Applications, Proceedings, 2018, art. no. 8572066, pp. 279-284.

GLOMB, T., KAŠE, V., HEŘMÁNKOVÁ, P. Popularity of the cult of Asclepius in the times of the Antonine Plague: Temporal modeling of epigraphic evidence. Journal of Archeological Science> Reports 2022, vol 43, art.no. 103466, DOI:10.1016/j.jasrep.2022.103466
GLOMB, T. The spread of the cult of Asclepius in the context of the Roman army benefited from the presence of physicians: A spatial proximity analysis. PLoS ONE 2021, vol. 16, no. 8, art.no. e0256356.
GLOMB, T., MERTEL, A., POSPÍŠIL, Z., CHALUPA, A. Ptolemaic political activities on the west coast of Hellenistic Asia Minor had a significant impact on the local spread of the Isiac cults: A spatial network analysis. PLoS ONE 2020, vol. 15, no. 4, e0230733.
MERTEL, A., STACHOŇ, Z., GLOMB, T., HAMPEJS, T., KAŠE, V., CHALUPA, A., PAPOUŠEK, D. The role of spatial visual analysis in historical religious studies. Geografie 2019, vol. 124, no. 3, pp. 265-280
FOUSEK, J., KAŠE, V., MERTEL, A., VÝTVAROVÁ, E., CHALUPA, A. Spatial constraints on the diffusion of religious innovations: The case of early Christianity in the Roman Empire. PLoS ONE 2018, vol. 13, no. 12, art.no. e0208744.

back

ČERVINEK, L., ČERNÁ, O, ČANIGA, M., KONÍŘOVÁ, E., HLUŠÍ, A., SIMKOVIC, M, POSPÍŠIL, Z., ČERMÁK, J., KOZÁK, T., MAYER, J., DOUBEK, M. Efficacy of rituximab in primary immune thrombocytopenia: an analysis of adult pretreated patients from everyday hematological practice. International journal of hematology 2012, vol. 96, no. 5, p. 594-599.

MELIKYAN, A.L., PUSTOVAYA, E.I., TSVETAEVA, N.V., EGOROVA, E.K., DANISHYAN, K.I. GALSTYAN, G.M. Guidelines for the diagnosis and management of idiopathic thrombocytopenic purpura. Gematologia i transfuziologia 2024, vol. 68, no. 4, p. 530-555. DOI: 10.35754/0234-5730-2022-68-4-530-555
HANIF, M., SIVAPALARATNAM, S., PROVAN, D. Novel insights in medical management of immune thrombocytopenia. Anals of Blood 2021, vol. 6, Art.No. 8, doi: 10.21037/aob-21-7
DESHAYES, S., MAHÉVAS, M., GODEAU, B. Rituximab and immune thrombocytopenia in adults: The state of knowledge 20 years later. La Revue de Médicine Interne 2021, vol. 42, no. 1. p. 32-37.
EBBO, M., RIVIÈRE, E., GODEAU, B. Agonistes du récepteur de la thrombopoïétine et purpura thrombopénique immunologique de l'adulte : où en sommes-nous 10 ans après? [Adult immune thrombocytopenia and thrombopoietin receptor agonist: Ten years later] La Revue de Médicine Interne 2021, vol. 42, no. 1. p. 38-45.
MISHRA, K., KUMAR, S., JANDIAL, A., SAHU, K.K., SANDAL, R., AHUJA, A., KHERA, S., UDAY, Y., KUMAR, R., KAPOOR, R., VERMA, T., SHARMA, S., SINGH, J., DAS, S., CHATTERJEE, T., SHARMA, A., NAIR, V. Real-world Experience of Rituximab in Immune Thrombocytopenia. Indian Journal of Hematology and Blood Transfusion 2021, DOI: 10.1007/s12288-020-01351-3
AL-SAMKARI, H., KUTER, D.J. Immune Thrombocytopenia in Adults: Modern Approaches to Diagnosis and Treatment. Semin. Thromb. Hemost. 2020, vol. 40, no. 3, p. 275-288.
PROVAN, D., ARNOLD, D.M., BUSSEL, J.B., CHONG, B.H., COOPER, N., GERNSHEIMER, T., GHANIMA, W., GODEAU, B., GONZALEZ-LOPEZ, T.J., GRAINGER, J., HOU, M., KRUSE, C., McDONALD, V., MICHEL, M., NEWLAND, A.C., PAVORD, S., RODEGHIERO, F., SCULLY, M., TOMIYAMA, Y., WONG, R.S., ZAJA, F., KUTER, D.J. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Advances 2019, vol. 3, no. 22, p. 3780-3817.
LUCCHINI, E., ZAJA, F., BUSSEL, J. Rituximab in the treatment of immune thrombocytopenia: what is the role of this agent in 2019? Haematologica 2019, vol. 104, no. 6, p. 1124-1135.
FUJIMI, A., KAMIHARA, Y., KANISAWA, Y., HASHIMOTO, A., NAKAJIMA, C., HAYASAKA, N., UEMURA, N., OKUDA, T., MINAMI, S., IYAMA, S., TAKADA, K., SATO, T., HARA, A., IWATA, Y., FURUICHI, k., WADA, T., KATO, J. Anti-erythropoietin receptor antibody-associated pure red cell aplasia accompanied by Coombs-negative autoimmune hemolytic anemia in a patient with T cell/histiocyte-rich large B cell lymphoma. International journal of hematology 2014, vol. 100, no. 5, p. 490-493.
LEVY, R., MAHEVAS, M., GALICIER, L., BOUTBOUL, D., MOROCH, J., LOUSTAU, V., GUILLAUD, C., LANGUILLE, L., FAIN, O., BIERLING, P., KHELLAF, M., MICHEL, M., OKSENHENDLER, E., GODAU, B. Profound symptomatic hypogammaglobulinemia: A rare late complication after rituximab treatment for immune thrombocytopenia. Report of 3 cases and systematic review of the literature. Autoimmunity Reviews 2014, vol. 13, no. 10, p. 1055-1063.

ŽIBŘIDOVÁ, K., KONÍŘOVÁ, E., KOŠŤÁL, M. Nové trendy v léčbě imunitní trombocytopenie v době pandemie COVID-19 [New trends in the treatment of immune thrombocytopenia during the COVID-19 pandemic]. Transfúze a hematologie dnes 2022, vol. 28, no. 3, p. 144-149.
ZÍTKOVÁ, M., MAYER, J., KRÁL, Z., JUŘENÍKOVÁ, P. Kvantifikace ošetřovatelské péče v oboru hematoonkologie. [Quantification of nursing care in haemato-oncology.] Transffúze a hematologie dnes 2015, vol. 21, no. 2, p. 101-108.

back

KREJČÍ, M., KAMELANDER, J., POSPÍŠIL, Z., MAYER, J. Kinetics of bilirubin and liver enzymes is useful for predicting of liver graft-versus-host disease. Neoplasma 2012, vol. 59, no. 3, p. 264-268.

WANG, W., YOU, L., HUANG, K., LI, Z., HU, Y., GU, S., LI, Y., XIAO, J. A nomogram model for predicting ocular GVHD following allo-HSCT based on risk factors. BMC Ophthalmology 2023, vol. 23, art.no. 28 DOI: 10.1186/s12886-022-02745-9
SABATELLI, L., KERÄNEN, M., VIAYNA, E., ROSET, M., LARA, N., THUNSTRÖM, D., PFEIFFER, M., NICKLASSON, M., ITÄLÄ-REMES, M. Burden of hospitalizations and outpatient visits associated with moderate and severe acute graft-versus-host disease in Finland and Sweden: a real-world data study. Supportive Care in Cancer 2022, DOI: 10.1007/s00520-022-06915-9
CROWELL, K., R., PATEL, R, A., FLUCHEL, M., LOWICHIK, A., BRYSON, S., Pohl, J, F. Endoscopy in the Diagnosis of Intestinal Graft-Versus-Host Disease: Is Lower Endoscopy With Biopsy as Effective in Diagnosis as Upper Endoscopy Combined With Lower Endoscopy? PEDIATRIC BLOOD & CANCER 2013, vol. 60, no. 11, p. 1798-1800.

back

ELBL, L., VÁŠOVÁ, I., TOMÁŠKOVÁ, I., JEDLIČKA, F., NAVRÁTIL, M., POSPÍŠIL, Z., VORLÍČEK, J. Cardiac function and cardiopulmonary performance in patients after treatment for non-Hodgkin's lymphoma. NEOPLASMA 2006, vol. 53, no. 2, p. 174-181.

LALA, A., TAYAL, U., HAMO, C.E., YOUMANS, Q., AL-KHATIB, S.M., BOZKURT, B., DAVIS, M.B., JANUZZI, J., MENTZ, R., SAUER, A., WALSH, M.N., YANCY, C., GULATI, M. Sex Differences in Heart Failure. Journal of Cardiac Failure, 2022, vol. 28, no. 3, p. 477-498. doi: 10.1016/j.cardfail.2021.10.006
BENNETT, S., CUBUKCU, A., WONG, C.W., GRIFFITH, T., OXLEY, C., BARKER, D., DUCKETT, S., SATCHITHANANDA, D., PATWALA, A., HEATLIE, G., KWOK, C.S. The role of the Tei index in assessing for cardiotoxicity from anthracycline chemotherapy: a systematic review . Echo Research and Practice 2021, vol. 8, no. 1, doi: 10.1530/ERP-20-0013.
MEINERS, B., SHENOY, C., ZORDOKY, B.N. Clinical and preclinical evidence of sex-related differences in anthracycline-induced cardiotoxicity. BIOLOGY OF SEX DIFFERENCES 2018, doi: 10.1186/s13293-018-0198-2
SZMIT, S., JURCZAK, W., ZAUCHA, J.M., DROZD-SOKOLOWSKA, J., SPYCHALOWICZ, W., JOKS, M., DLUGOSZ-DANECKA, M., TORBICKI, A. Pre-existing arterial hypertension as a risk factor for early left ventricular systolic dysfunction following (R)-CHOP chemotherapy in patients with lymphoma. JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION 2014, vol. 8, no. 11, p. 791-799.
BUSIA, A, LAFFRANCHI, A, VIVIANI, S, BONFANTE, V, VILLANI, F. Cardiopulmonary Toxicity of Different Chemoradiotherapy Combined Regimens for Hodgkin's Disease. Anticancer Research 2010, vol. 30, no. 10, p. 4381-4387.
PROVENCIO, M., SANCHEZ, A., MAXIMIANO, C., CANTOS, B., MENDEZ, M., BONILLA, F. A prospective study of left ventricle function after treatment with rapid-infusion Rituximab in patients with non-Hodgkin lymphoma. Leukemia & Lymphoma 2009, vol. 50, no. 10, p. 1642-1646.
VILLANI, F., BUSSIA, A., VILLANI, M., LAFFRANCHI, A., VIVIANI, S., BONFANTE, F. Cardiopulmonary response to exercise in patients with different degrees of lung toxicity after radio-chemotherapy for Hodgkin's disease. Anticancer Research 2009, vol. 29, no. 2, p. 777-783.
PUDIL, R., HORÁČEK, J.M., STRASOVÁ, A., JEBAVÝ, L., VOJÁČEK, J. Monitoring of the very early changes of left ventricular diastolic function in patients with acute leukemia treated with anthracyclines. Experimental Oncology 2008, vol. 30, no. 2, p. 160-162.
VAN WEERT, E., HOEKSTRA-WEEBERS, J.E.H.M., MAY, A.M., KORSTJENS, I., ROS, W.J.G., VAN DER SCHANS, C.P. The development of an evidence-based physical self-management rehabilitation programme for cancer survivors. Patient Education and Counseling 2008, vol. 71, no. 2, p. 169-190.
BRUYNZEEL, A., M., E., ABOU, EL, HASSAN, M., A., SCHALKWIJK, C., BERKHOF, J., BAST, A., NIESSEN, H., W., M., VAN der VIJGH, W., J., F. Anti-inflammatory agents and monoHER protect against DOX-induced cardiotoxicity and accumulation of CML in mice. British Journal of Cancer 2007, vol. 96, no. 6, p. 937-943.

back

PAVLÍK, T., JANOUŠOVÁ, E., POSPÍŠIL, Z., MUŽÍK, J., ŽÁČKOVÁ, D., RÁČIL, Z., CETKOVSKÝ, P., TRNĚNÝ, M., MAYER, J., DUŠEK, L. Estimation of current cumulative incidence of leukaemia-free patients and current leukaemia-free survival in chronic myeloid leukaemia in the era of modern pharmacotherapy. BMC Medical Research Methodology 2011

PERUSINI, M. A., NOVITZKY-BASSO, I., ATENAFU, E. G., FORREST D., BENCE-BRUCKLER I., SAVOIE, L., KEATING, M.M.,BUSQUE, L., DELAGE, R., XENOCOSTAS, A., LIEW, E., LANEUVILLE, P., PAULSON, K., STOCKLEY, T., LIPTON, J.H., LEBER, B., KIM, D.D.H. Final report of TKI discontinuation trial with dasatinib for the second attempt of treatment-free remission after failing the first attempt with imatinib: Treatment-free Remission Accomplished by Dasatinib (TRAD) study. British Journal of Haematology 2023, DOI: 10.1111/bjh.19058.
NAKASONE, H., KAKO, S., TACHIBANA, T., TANAKA. M., ONIYUKA, M., TAKAHASHI, S., YOKOTA, A., FUJIWARA, S.-I., SAKURA, T., SAKAIDA. E., FUJISAWA, S., YAMAZAKI, R. Novel Indicators of Transplant Outcomes for PhALL: Current Molecular-Relapse-Free Survival. Transplantation and Cellular Therapy 2021, vol. 27, no. 9, p. 800.e1--800.e8, doi: 10.1016/j.jtct.2021.06.020
NAKASONE, H., KAKO, S., MORI, T., TAKAHASHI, S., ONIZUKA, M., FUJIWARA, S., SAKURA, T., SAKAIDA, E., YOKOTA, A., AOTSUKA, N., HAGIHARA, M., TSUKADA, N., HATTA, Y., USUKI, K., WATANABE, R., GOTOH, M., FUJISAWA, S., YANO, S., KANAMORI, H., OKAMOTO, S., KANDA, Y. Stopping tyrosine kinase inhibitors started after allogeneic HCT in patients with Philadelphia chromosome-positive leukemia. Bone Marrow Transplantation 2021, doi: 10.1038/s41409-020-01206-5.
OHWADA, C., SAKAIDA, E., IGARASHI, A., KOBAYASHI, T., DOKI, N., MORI, T., KATO, J., KODA, Y., KANAMORI, H., TANAKA, M., TACHIBANA, T., FUJISAWA, S., NAKAJIMA, Y., NUMATA, A., TOYOSAKI, M., AOYAMA, Y., ONIZUKA, M., HAGIHARA, M., KOYAMA, S., KANDA, Y., NAKASONE, H., SHIMIZU, H., KATO, S., WATANABE,R., SHONO, K., SAKAI, R., SAITO, T., NAKASEKO, C., OKAMOTO, S. A Prospective, Longitudinal Observation of the Incidence, Treatment, and Survival of Late Acute and Chronic Graft-versus-Host Disease by National Institutes of Health Criteria in a Japanese Cohort. Biology of Blood and Marrow Transplantation 2020, vol. 26, no. y1, p.162-170.
HORVÁTH, R., HURŇÁKOVÁ, J., JANKOVÁ, R., PHILIPP, T., SZCZUKOVÁ, L.,HEJDUK, K.,PAVELKA, K. Účinnost první a následné linie léčby adalimumabem u revmatoidní artritidy: analýza dat Českého národního registru ATTRA. [Efficacy of the first and subsequent treatment lines with adalimumab in patients with rheumatoid arthritis: Data analysis from the Czech National Registry ATTRA.] Česká Revmatologie 2016, vol. 24, no. 3, p. 78-91.
LAUSEKER, M., HASFORD, J., HOFFMANN, V.S., MÜLLER, M.C., HEHLMANN, R., PFIRRMANN, M. A multi-state model approach for prediction in chronic myeloid leukaemia. Annals of Hematology 2015, vol. 94, p. 919-927.
GUILHOT, J., PREUDHOMME, C., MAHON, F.X., GUILHOT, F. Analyzing molecular response in chronic myeloid leukemia clinical trials: Pitfalls and golden rules. Cancer 2015, vol. 121, no. 4, p. 490-497.

PAVLÍK, T., JANOUŠOVÁ, E., INDRÁK, K., JAROŠOVÁ, M., KLAMOVÁ, H., ŽÁČKOVÁ, D., VOGLOVÁ, J., FABER, E., KARAS, M., MACHOVÁ POLAKOVA, K., RÁČIL, Z., DOMEČKOVÁ, E., DIMITROVIČOVÁ, L., TOTHOVÁ, E.,CHUDEJ, J., MARKULJAK, I., CMUNT, E., KOZÁK, T., MUŽÍK, J., DUŠEK, L. Current survival measures reliably reflect modern sequential treatment in CML: Correlation with prognostic stratifications. American Journal of Hematology 2013, vol. 88, no. 9, p. 790-797.
MALČÍKOVÁ, J., RÁZGA, F., JURČEK, T., DVOŘÁKOVÁ, D., ŽÁČKOVÁ, D., TOSKOVÁ, M., SEBEJOVÁ, L., ŠMARDOVÁ, J., OLTOVÁ, A., VAŇKOVÁ, G., JURÁČKOVÁ, L., TRBUŠEK, M., POSPÍŠILOVÁ, Š., MAYER, J., RÁČIL, Z. The BCR-ABL1 T315I mutation and additional genomic aberrations are dominant genetic lesions associated with disease progression in patients with chronic myelogenous leukemia resistant to tyrosine kinase inhibitor therapy. Leukemia and Lymphoma 2013, vol. 54, no. 9, p. 2083-2087.

back

DOUBEK, M., MAYER, J., OBRTLÍKOVÁ, P., SMOLEJ, L., CMUNT, E., SCHWARZ, J., BREJCHA, M., KOZMON, P., POSPÍŠILOVÁ, Š., BRYCHTOVÁ, Y., POSPÍŠIL, Z., TRNĚNÝ, M. Modern and conventional prognostic markers of chronic lymphocytic leukaemia in the everyday haematological practice. European Journal of Haematology 2011, vol. 87, no. 2, p. 130-137.

LOPATNIUK, P., PUCHALSKA, Z., MITAL, A., MIKOSIK, A., FRACKOWIAK, J., HELLMANN, A., DACA, A., BRYL, E., FULOP, T., WITKOWSKI, J.M. Excessive amount and activity of mu-calpain affects apoptotic machinery in chronic B-cell leukemia cells and influences the course of the disease. Acta Biochimica Polonica 2020, vol. 67, no. 2, p. 247-257.
VOSOUGHI, T., BAGHERI, M., HOSSEINZADEH, M., EHSANPOUR, A., DAVARI, N., SAKI, N. CD markers variations in chronic lymphocytic leukemia: New insights into prognosis. Journal of Cellular Physiology 2019, vol. 234, no. 11, p. 19420-19439.
WITKOWSKA, M., MAJCHRZAK, A., CEBULA-OBRZUT, B., WAWRZYNIAK, E., ROBAK, T., SMOLEWSKI, P. The distribution and potential prognostic value of SMAD protein expression in chronic lymphocytic leukemia. Tumor Biology 2017, vol. 39, no. 3, 10.1177/1010428317694551
PFEILSTÖCKER, M., WEICHSELBAUM, R., MÜHLBERGER, H., MENSCHEL, E., KEIL, F. Potential impact of the hypomethylating agent 5-azacitidine on chronic lymphocytic leukemia with del(17)(p)/del(p53) and subsequent therapy-related acute myeloid leukemia without these aberrations: a case report. memo-Magazine of European Medical Oncology 2015, vol. 8, p. 144-147.
NEDERBY, L., ROUG, A.S., KNUDSEN, S.S., SKOVBO, A., KJELDSEN, E., MOLLER, H.J., HOKLAND, M. Soluble CD163 as a prognostic biomarker in B-cell chronic lymphocytic leukemia. Leukemia & Lymphoma 2015, vol. 56, no. 11, p.3219-3221.
PFLUG, N., BAHLO, J., SHANAFELT, T.D., EICHHORST, B.F., BERGMANN, M.A., ELTER, T., BAUER, K., MALCHAU, G., RABE, K.G., STILGENBAUER, S., DOHNER, H., JAGER, U., ECKART, M.J., HOPFINGER, G., BUSCH, R., FINK, A.M., WENDTNER, C.M., FISCHER, K., KAY, N.E., HALLEK, M. Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemia. Blood 2014, vol. 124, no. 1, p. 49-62.
HAN, T.T., FAN, L., LI, J.Y., XU, W. Role of chemokines and their receptors in chronic lymphocytic leukemia. Function in microenvironment and targeted therapy. Cancer Biology & Therapy 2014, vol. 15, no. 1, p. 3-9.
JANSSENS, A. Treatment of chronic lymphocytic leukemia. Transfusion and Apheresis Science 2013, vol. 49, no. 1, p. 44-50.
FAHRMANN, J.F., BALLESTER, O.F., BALLESTER, G., WITTE, T.R., SALAZAR, A.J., KORDUSKY, B., COWEN, K.G., ION, G., PRIMERANO, D.A., BOSKOVIC, G., DENVIR, J., HARDMAN, W.E. Inhibition of Nuclear Factor Kappa B activation in Early-Stage Chronic Lymphocytic Leukemia by Omega-3 Fatty Acids. Cancer Investigation 2013, vol. 31, no. 1, p. 29-43.
BAZARGAN, A, TAM, C.S., KEATING, M.J. Predicting survival in chronic lymphocytic leukemia. Expert Review of Anti-infective Therapy 2012, vol. 12, no. 3, p. 393-403, doi:10.1586/era.12.2.
STERLACCI, W., STOCKINGER, R., FIEGL, M. Gender and oncology: Pathological observations. Memo - Magazine of European Medical Oncology 2011, vol. 4, no. 4, p. 236-240.
FIEGL, M., THÖNI, C., HOCHLEITNER, M. Gender aspects in haematology and oncology: Overview and own observations in lung cancer. memo-Magazine of European Medical Oncology 2011, vol. 4, no. 4, p. 209-216.

STEHLÍKOVÁ, O., CHOVANCOVÁ, J., TICHÝ, B., KREJČÍ, M., BRYCHTOVÁ, Y., PANOVSKÁ, A., SKUHROVÁ FRANCOVÁ, A., BURČKOVÁ, K., BORSKÝ, M., LOJA, T., MAYER, J., POSPÍŠILOVÁ, Š., DOUBEK, M. Detecting minimal residual disease in patients with chronic lymphocytic leukemia using 8-color flow cytometry protocol in routine hematological practice. International Journal of Laboratory Hematology 2014, vol. 36,no. 2, p. 165-171.
BREJCHA, M., STOKLASOVÁ, M., BRYCHTOVÁ, Y., PANOVSKÁ, A., ŠTĚPANOVSKÁ K., VANKOVÁ, G., PLEVOVÁ, K., OLTOVÁ, A., HORKÁ, K., POSPÍŠILOVÁ, Š., MAYER, J., DOUBEK, M. Clonal evolution in chronic lymphocytic leukemia detected by fluorescence in situ hybridization and conventional cytogenetics after stimulation with CpG oligonucleotides and interleukin-2: A prospective analysis. Leukemia Research 2014, vol. 38,no. 2, p. 170-175.
KREJČÍ, M., DOUBEK, M., BRYCHTOVÁ, Y., STEHLÍKOVÁ, O., CHOVANCOVÁ, J., TICHÝ, B., SKUHROVÁ FRANCOVÁ, A., NAVRÁTIL M., TOMIŠKA, M., HORKÝ, O., POSPÍŠILOVÁ, Š., MAYER, J. Fludarabine with cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with poor-risk chronic lymphocytic leukemia. Annals of Hematology 2013, vol. 9, p. 249-254, doi:10.1007/s00277-012-1579-y
PANOVSKÁ, A., SMOLEJ, L., LYSÁK, D., BRYCHTOVÁ, Y., ŠIMKOVIČ, M., MOTYČKOVÁ, M., VODÁREK, P., LINDTNEROVÁ, M., TRBUŠEK, M., MALČÍKOVÁ, J., POSPÍŠILOVÁ, Š., MAYER, J., DOUBEK, M. The outcome of chronic lymphocytic leukemia patients who relapsed after fludarabine, cyclophosphamide, and rituximab. European Journal of Haematology 2013, vol. 90, no. 6, p. 479-485.
OBRTLÍKOVÁ, P. Moderní individualizovaná léčba chronické lymfocytární leukemie [Modern, individualized treatment of chronic lymphotic leukemia]. Onkologie (Switzerland) 2013, vol. 7, no. 1, p. 24-28.

back

ŽÁČKOVÁ, D., KLAMOVÁ, H., DUŠEK, L., MUŽÍK, J., POLÁKOVÁ, K., M., MORAVCOVÁ, J., JURČEK, T., DVOŘÁKOVÁ, D., RÁČIL, Z., POSPÍŠIL, Z., OLTOVÁ, A., MICHALOVÁ, K., BŘEZINOVÁ, J., RÁZGA, F., DOUBEK, M., CETKOVSKÝ, P., TRNĚNÝ;, M., MAYER, J. Imatinib as the first-line treatment of patients with chronic myeloid leukemia diagnosed in the chronic phase: Can we compare real life data to the results from clinical trials? American Journal of Hematology 2011, vol. 86, no. 3, p. 318-321.

BADIOLA, L.B., MILAGRO, N.L., LAVÍN, D.C., PAREITA, S.L., IBARBIA, M.A., KAREAGA, M.M., FERNÁNDEZ DEL RIVERO, T., OTERO, D.S., LÓPEZ, V.A., FERNÁNDEZ, C.Á., EMBORUJO, A.L., ARNAIZ, I.G. RENO Study: Clinical characteristics, treatment patterns and survival results in patients with metastatic renal cell carcinoma in Northern Spain. Seminars in Oncology, 2024, DOI: 10.1053/j.seminoncol.2024.02.002
FABER, E., INDRÁK, K. Vývoj léčby chronické myeloidní leukemie v posledních 25 letech [Development of chronic myeloid leukaemia treatment over the past 25 years]. Transfúze a hematologie dnes 2019, vol. 25, no. 1, p. 118-124.
MAROUN, R., MITROFAN, L., BENJAMIN, L., NACHBAUR, G., MAUNOURY, F., Le JEUNNE, P., DURAND-ZALESKI, I. Real life patterns of care and progression free survival in metastatic renal cell carcinoma patients: retrospective analysis of cross-sectional data. BMC Cancer 2018, vol. 18, 10.1186/s12885-018-4117-z
GAMBACORTI-PASSERINI, C., PIAZZA, R. How I treat newly diagnosed chronic myeloid leukemia in 2015. American Journal of Hematology 2015, vol. 90, no. 2, p. 156-161.
VIGANO, I., DI GIACOMO, N., BOZZANI, S., ANTOLINI, L., PIAZZA, R., PASSERINI, C.G. First-line treatment of 102 chronic myeloid leukemia patients with imatinib: A long-term single institution analysis. American Journal of Hematology 2014, vol. 89, no. 10, p. E184-E187, DOI: 10.1002/ajh.23804
SMITH, A.G., PAINTER, D., HOWELL, D.A., EVANS, P., SMITH, G., PATMORE, R., JACK, A., Roman, E. Determinants of survival in patients with chronic myeloid leukaemia treated in the new era of oral therapy: findings from a UK population-based patient cohort . BMJ Open 2014, vol. 4, no. 1. article no. e004266, DOI: 10.1136/bmjopen-2013-004266
YILMAZ, M., KANTARJIAN, H., JABBOUR, E., O'BRIEN, S., BORTHAKUR, G., VERSTOVSEK, S., GARCIA-MANERO, G., RAVANDI, F., BURGER, J., PIERCE, S., QUINTAS-CARDAMA, A., CORTES, J. Similar outcome of patients with chronic myeloid leukemia treated with Imatinib in or out of clinical trials. Clinical Lymphoma Myeloma & Leukemia 2013, vol. 13, no. 6, p. 693-699.
TÓTHOVÁ, E., KAFKOVÁ, A. Biologická liečba chronickej myelocytovej leukémie [Biological therapy of chronic myeloid leukemia]. Onkologie 2012, vol. 6, no. 4, p.208-213.
CORTES, J., KANTARJIAN, H. How I treat newly diagnosed chronic phase CML. Blood 2012, vol. 120, no. 7, p. 1390-1397.

ŽÁČKOVÁ, D., KLAMOVÁ, H., BĚLOHLÁVKOVÁ, P., STEJSKAL, L., NEČASOVÁ, T., SEMERÁD L., WEINBERGEROVÁ B., SRBOVÁ D., VOGLOVÁ J., CICÁTKOVÁ P., ŠUSTKOVÁ Z., HORŇÁK T., BARANOVÁ J., PROCHÁZKOVÁ J., MAYER J. Dasatinib treatment long-term results among imatinib-resistant/intolerant patients with chronic phase chronic myeloid leukemia are favorable in daily clinical practice. Leukemia&Lymfoma 2020, doi: 10.1080/10428194.2020.1827242
KLAMOVÁ, H. Současný stav léčby chronické myeloidní leukemie pomocí inhibitorů tyrozinové kinázy. [Current approach for chronic myeloid leukemia treatment with tyrosin kinase inhibitors.] Onkologie 2016, vol. 10, no. 3, p. 120-126.
ŽÁČKOVÁ, D. Chronická myeloidní leukemie v roce 2015. [Chronic myeloid leukemia in 2015.] Onkologie 2015, vol. 9, no. 3, p. 119-122.
ZÍTKOVÁ, M., MAYER, J., KRÁL, Z., JUŘENÍKOVÁ, P. Kvantifikace ošetřovatelské péče v oboru hematoonkologie. [Quantification of nursing care in haemato-oncology.] Transffúze a hematologie dnes 2015, vol. 21, no. 2, p. 101-108.
RÁČIL, Z., RÁZGA, F., KLAMOVÁ, H., VOGLOVÁ, J., BĚLOHLÁVKOÁ, P., MALÁŠKOVÁ, L., POTĚŠIL D., MUŽÍK, J., ŽÁČKOVÁ, D., POLÁKOVÁ MACHOVÁ, K., ZDRÁHAL, Z., MALÁKOVÁ, J., DYR, J., MAYER, J. No clinical evidence for performing trough plasma and intracellular imatinib concentrations monitoring in patients with chronic myelogenous leukaemia. Hematological Oncology 2014, vol. 32, no. 2, p. 87-93.
ŽÁČKOVÁ, D., KLAMOVÁ, H., MUŽÍK, J., CMUNT, E., RÁČIL, Z., POLÁKOVÁ MACHOVÁ, K., DVOŘÁKOVÁ, D., JURČEK, T., RÁZGA, F., CETKOVSKÝ, P., DUŠEK, L., MAYER, J. Efficacy and tolerance of dasatinib after imatinib failure or intolerance for patients with chronic myeloid leukemia treated in three different hospitals compare well with results achievable in formal clinical trials. Leukemia & Lymphoma 2013, vol. 54, no. 10, p. 2310-2313.
PAVLÍK, T., JANOUŠOVÁ, E., MAYER, J., INDRÁK K., JAROŠOVÁ, M., KLAMOVÁ, H., ŽÁČKOVÁ, D., VOGLOVÁ, J., FABER, E., KARAS, M., POLÁKOVÁ, K., M., RÁČIL, Z., DEMEČKOVÁ, E., DIMITROVIČOVÁ, L., TOTHOVÁ, E., CHUDĚJ, J., MARKULJAK, I., CMUNT, E., MUŽÍK, J., , DUŠEK, L. Current survival measures reliably reflect modern sequential treatment in CML: Correlation with prognostic stratifications. American Journal of Hematology 2013, vol. 88, no. 9, p. 790-797.
KLAMOVÁ, H. Chronická myeloidní leukemie - Zásadní změna prognózy nemocných po zavedení léčby inhibitory tyrozinových kináz [Chronic myeloid leukaemia - A crucial change to the patient prognosis after an introduction of tyrosine kinase inhibitors]. Vnitřní lékařství 2012, vol. 58, no. SUPPL.2, p. 2S27-2S37.
GUILHOT, J., BACCARANI, M., CLARK, R.E., CERVANTES, F., GUILHOT, F., HOCHHAUS, A., KULIKOV, S., MAYER, J., PETZER, A.L., ROSTI, G., ROUSSELOT, P., SAGLIO, G., SAUSSELE, S., SIMONSSON, B., STEEGMANN, J.L., ZARITSKEY, A., HEHLMANN, R. Definitions, methodological and statistical issues for phase 3 clinical trials in chronic myeloid leukemia: a proposal by the European LeukemiaNet. Blood 2012, vol. 119, no. 25, p. 5963-5971.

back

BUŇKOVÁ, L., BUŇKA, F., JANIŠ, R., KREJČÍ, J., DOLEŽÁLKOVÁ, I., POSPÍŠIL, Z., RŮŽIČKA, J., TREMLOVÁ, N. Comparison of antibacterial effect of seven 1-monoglycerides on food-borne pathogens or spoilage bacteria. Acta Veterinaria Brno 2011, vol. 80, no. 1, p. 29-39.

LIU, T., RUAN, S.Y., MO, Q.F., ZHAO, M.J., WANG, J., YE, Z.Y., CHEN, L., FENG, F.Q. Evaluation of dynamic effects of dietary medium-chain monoglycerides on performance, intestinal development and gut microbiota of broilers in large-scale production. Animal Nutrition 2023, vol. 14, p. 269-280 DOI: 10.1016/j.aninu.2023.05.0032405-6545
NGATIRAH, N., HIDAYAT, C., RAHAYU, E.S., UTAMI, T. Antibacterial Activity of the Purified Monolaurin from Enzymatic Glycerolysis of Palm Kernel Olein-Stearin against Bacillus subtilis. Applied Food Biotechnology 2023, vol. 10, no. 2,p. 129-140.
ARZOLA-ALVAREZ, C, RUIZ-BARRERA, O., CASTILLO-CASTILLO, Y. ONTIVEROS, M., FONSECA, M., JONES, B.W., SMITH, W.B., HUME, M.E., HARVEY, R., POOLE, T.L., ANDERSON, R.C., ARZOLA-RUBIO, A., SALINAS-CHAVIRA, J. Effects in air-exposed corn silage of medium chain fatty acids on select spoilage microbes, zoonotic pathogens, and in vitro rumen fermentation. Journal of Environmental Science and Health, Part B 2023, DOI: 10.1080/03601234.2023.2168449 (Early Access)
NGATIRAH, N., HIDAYAT, C., RAHAYU, E.S., UTAMI, T. Enzymatic Glycerolysis of Palm Kernel Olein-Stearin Blend for Monolaurin Synthesis as an Emulsifier and Antibacterial. Foods, 2022, vol. , no. 16, art.no. 2412, DOI: 10.3390/foods11162412
BAJAJ H., KAUSHAL, S., KALIA, A., Kaur, V. Proximate, mineral, chemical composition, antioxidant and antimicrobial potential of dropped fruits of Citrus reticulata Blanco. Journal of Food Measurement and Characterization 2022, DOI: 10.1007/s11694-022-01532-w (Early Access)
NITBANI, F.O., TJITDA, P.J.P., NITTI, F., JUMINA, J., DETHA, A.I.R. Antimicrobial Properties of Lauric Acid and Monolaurin in Virgin Coconut Oil: A Review. ChemBioEng Reviews 2022, DOI: 10.1002/cben.202100050
LIU, T., GUO, L., ZHANGYING, Y., RUAN, S., LIU, W., ZHANG, X., Feng, F. Dietary medium-chain 1-monoglycerides modulates the community and function of cecal microbiota of broilers. Journal of the Science of Food and Agriculture 2021, DOI: 10.1002/jsfa.11562
FADHLINA, A., SARKER, Z.I., MAJID, F.A.A., SHEIKH, H.I. GC-MS analysis and antimicrobial activity of Stereospermum fimbriatum against selected skin-associated pathogens. Jurnal Teknologi-sciences & Engineering 2021, vol. 83, no. 5, DOI: 10.11113/jurnalteknologi.v83.16972
PEER, P., SEDLAŘÍKOVÁ, J., JANALÍKOVÁ, M., KUČEROVÁ, L., PLEVA, P. Novel polyvinyl butyral/monoacylglycerol nanofibrous membrane with antifouling activity. Materials 2020, vol. 13, no. 17, DOI: 10.3390/ma13173662
MATĚJKOVÁ, K., KŘÍŽEK, M., DADÁKOVÁ, E., VÁCHA, F., PELIKÁNOVÁ, T. Effects of monoacylglycerols and chitosan on the biogenic amine formation in the flesh of rainbow trout (Oncorhynchus mykiss). Czech Journal of Food Sciences 2020, vol. 38, no. 3, p. 164-170.
WANG, W., WANG, R., ZHANG, G., CHEN, F., XU, B. In Vitro Antibacterial Activities and Mechanisms of Action of Fatty Acid Monoglycerides against Four Foodborne Bacteria. Journal Of Food Protection 2020, vol. 83, no. 2, p. 331-337. DOI: 10.4315/0362-028X.JFP-19-259
LALOUČKOVÁ, K., MALÁ, L., SLANIČKOVÁ, P., SKŘIVANOVÁ, E. In vitro antimicrobial effect of palm oils rich in medium-chain fatty acids against mastitis-causing Gram-positive bacteria. Czech Journal of Animal Science 2019, vol. 64,no. 8, p. 325-331.
HOVORKOVÁ, P., LALOUČKOVÁ, K., SKŘIVANOVÁ, E. Determination of In Vitro Antibacterial Activity of Plant Oils Containing Medium-Chain Fatty Acids against Gram-Positive Pathogenic and Gut Commensal Bacteria. Czech Journal of Animal Science 2018, vol. 63,no. 3, p. 119-125.
RONGPAN, S., PHONNOK, S., BOONDIREKE, S., TRIPINYOPAP, N., WONGSATAYANON, B. Anti-proliferative effect of long-chain monoglyceride derivatives on human cervical carcinoma cell line. Journal of the Medical Association of Thailand 2017, vol. 100, no. 10, p. S165-S172.
MAHESWARI, P., REVATHI, K. Antimicrobial effects of 1-monocaprylin and 1-monocaproin through in vitro growth inhibition and molecular docking studies. American Journal of Biochemistry and Biotechnology 2017, vol. 13, no. 3, p. 123-131.
HAM, Y., KIM, T-J. Inhibitory activity of monoacylglycerols on biofilm formation in Aeromonas hydrophila, Streptococcus mutans, Xanthomonas oryzae, and Yersinia enterocolitica. SPRINGERPLUS 2016, vol. 5, Art.No. 1526, DOI:10.1186/s40064-016-3182-5
NAKAYAMA, M., TOMIYAMA, D., IKEDA, K., KATSUKI, M., NONAKA, A., MIYAMOTO, T. Antibacterial Effects of Monoglycerol Fatty Acid Esters and Sucrose Fatty Acid Esters on Bacillus spp. Food Science and Technology Research 2015, vol. 21, no. 3, p. 431-437.
WEISS, D., KACZMAREK, A., STANGIERSKI, J. Applicability of bacterial growth models in spreadable processed cheese. Acta Scientiarum Polonorum, Technologia Alimentaria 2015, vol. 14, no. 3, p. 199-205.
ŠEVČÍKOVÁ, P., ADAMI, R., KAŠPÁRKOVÁ, V., REVERCHON, R., SEDLÁČEK, T., PASTOREK, M. Supercritical Assisted Atomization of emulsions for encapsulation of 1-monoacylglycerols in an hydrophilic carrier. Journal of Supercritical Fluids 2015, vol. 97, p. 183-191.
DAYRIT, F.M. The Properties of Lauric Acid and Their Significance in Coconut Oil. J. of the American Oil Chemists Society 2015, vol. 92, no. 1, p. 1-15.
MAROUNEK, M., PUTTHANA, V., BENADA, O., LUKEŠOVÁ, D. Antimicrobial Activities of Medium-chain Fatty Acids and Monoacylglycerols on Cronobacter sakazakii DBM 3157(T) and Cronobacter malonaticus DBM 3148. Czech Journal of Food Sciences 2012, vol. 30, no. 6, p. 573-580.
LORENCOVÁ, E., VLTAVSKÁ, P., BUDÍNSKÝ, P., KOUTNÝ, M. Antibacterial effect of phosphates and polyphosphates with different chain length. Journal of Environmental Science and Health. Part A 2012, vol. 47, no. 14, p. 2241-2245.

BUŇKOVÁ, L., BUŇKA, F. Microflora of processed cheese and the factors affecting it. Critical Reviews in Food Science and Nutrition 2017, vol. 57, no. 11, p. 2392-2403.
ŠEVČÍKOVÁ, P., KAŠPÁRKOVÁ, V., HAUERLANDOVÁ, L., HUMPOLÍČEK, P., KUCEKOVÁ, Z., BUŇKOVÁ, L. Formulation, antibacterial activity, and cytotoxicity of 1-monoacylglycerol microemulsions. Eur. J. Lipid Sci. Technol. 2014, vol. 116, no. 4, p. 448-457.
HAUERLANDOVÁ, I., LORENCOVÁ, E., BUŇKA, F., NAVRÁTIL, J., JANEČKOVÁ, K., BUŇKOVÁ, L. The influence of fat and monoacylglycerols on growth of spore-forming bacteria in processed cheese. International Journal of Food Microbiology 2014, vol. 182, p. 37-43.
DOLEŽÁLKOVÁ, I., JANIŠ, R., BUŇKOVÁ, L., SLOBODIAN, P., VÍCHA, R. Preparation, characterization and antibacterial activity of 1-monoacylglycerol of adamantane-1-carboxylic acid. Journal of Food Biochemistry 2013, vol. 37, no. 5, p. 544-553.
DOLEŽÁLKOVÁ, I., MACALÍK, Z., BUTKOVIČOVÁ, A., JANIŠ, R., BUŇKOVÁ, L. Monoacylglycerols as Fruit Juices Preservatives. Czech Journal of Food Sciences 2012, vol. 30, no. 6, p. 567-572.

back

MACHOVÁ-POLÁKOVÁ, K., POLÍVKOVÁ, V., RULCOVÁ, J., KLAMOVÁ, H., JURČEK, T., DVOŘÁKOVÁ, D., ŽÁČKOVÁ, D., POSPÍŠIL, Z., MAYER, J., MORAVCOVÁ, J. Constant BCR-ABL transcript level >= 0.1% (IS) in patients with CML responding to imatinib with complete cytogenetic remission may indicate mutation analysis. Experimental Hematology 2010, vol. 38. no. 1, p. 20-26.

SOVERINI, S., ALBANO, F., BASSAN, R., FABBIANO, F., FERRARA, F., FOÀ, R., OLIVIERI, A., RAMBALDI, A., ROSSI, G., SICA, S., SPECCHIA, G., VENDITTI, A., BAROSI, G., PANE, F. Next-generation sequencing for BCR-ABL1 kinase domain mutations in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A position paper. Cancer Medicine 2020, vol. 9, no. 9, p. 2960-2970.
SCHERER, F., KURTZ, D.M., DIEHN, M. ALIZADEH, A.A. High-throughput sequencing for noninvasive disease detection in hematologic malignancies. Blood 2017, vol. 130. no. 4, p. 440-452.
DARJI, A.A., BHARADIA, P.D. Chronic myelogenous leukemia: A review and update of current and future therapy. International Journal of Pharmacy and Pharmaceutical Sciences 2016, vol. 8. no. 7, p. 35-46.
CHAHARDOULI, B., ZAKER, F., MOUSAVI, S.A., SAFFARI, Z., NADALI, F., OSTADALI, M., GHADIMI, H., ALIMOGHADDAM, K., GHAVAMZADE, A., ROSTAMI, S. Detection of BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia on imatinib. Hematology 2013, vol. 18. no. 6, p. 327-332.
YEUNG, D., T., PARKER, W., T., BRANFORD, S. Molecular methods in diagnosis and monitoring of haematological malignancies. Pathology 2011, vol. 43, no. 6, p. 566-579.
AN, X., TIWARIA, A., K., SUNA, Y., DINGA, P-R., ASHBY, C., R., CHENA, Z-S. BCR-ABL tyrosine kinase inhibitors in the treatment of Philadelphia chromosome positive chronic myeloid leukemia: A review. Leukemia Research 2010, vol. 34, no. 10, p. 1255-1268.

BENEŠOVÁ, A., DE SANTIS, S., POLÍVKOVÁ, V., PECHERKOVÁ, P., KŘÍŽKOVÁ, J., SUCHÁNKOVÁ, P., MONALDI, C., KLAMOVÁ, H., SRBOVÁ, D., ŽIŽKOVÁ, H., HOCHHAUS, A., SOVERINI, S., MACHKOVÁ POLÁKOVÁ, K. Unstable major molecular response as a trigger for next generation sequencing-based BCR::ABL1 mutation testing in chronic myeloid leukemia. American Journal of Hematology 2024, DOI: 10.1002/ajh.27232
ROMZOVÁ, M., SMÍTALOVÁ, D., HYNŠT, J., TOM, N., LOJA, T., HERUDKOVÁ, Z., JURČEK, T., STEJSKAL, L., ŽÁCKOVÁ, D., MAYER, J., RÁČIL, Z., CULEN, M. Hierarchical distribution of somatic variants in newly diagnosed chronic myeloid leukaemia at diagnosis and early follow-up. British Journal of Haematology 2021, DOI: 10.1111/bjh.17659
POLÍVKOVÁ, V., BENEŠOVÁ, A., ŽIŽKOVÁ, H., KOBLIHOVÁ, J., CURIK, N., MOTLOVÁ, E., KLAMOVÁ, H., ŠÁLEK, C. MACHOVÁ POLÁKOVÁ,K. Sensitivity and reliability of DNA-based mutation analysis by allele-specific digital PCR to follow resistant BCR-ABL1-positive cells. Leukemia 2021, DOI: 10.1038/s41375-021-01226-0
ROMZOVÁ, M., SMÍTALOVÁ, D., TOM, N., JURČEK, T., CULEN, M., ŽÁČKOVÁ, D., MAYER, J., RÁČIL, Z. Novel Illumina-based next generation sequencing approach with one-round amplification provides early and reliable detection of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia. British Journal of Haematology 2020, DOI: 10.1111/bjh.16382
ŠMAHELOVÁ, J., KAŠTÁNKOVÁ, I., POLÁKOVÁ MACHOVÁ, K., KLAMOVÁ, H., ZEMANOVÁ K., TACHEZY R., HAMŠÍKOVÁ E., ŠMAHEL M. Expression of genes encoding centrosomal proteins and the humoral response against these proteins in chronic myeloid leukemia. Oncology Reports 2017, vol. 37, no. 1, p. 547-554.
TOMAN, O., KABIČKOVÁ, T., VÍT, O., FIŠER, R., POLÁKOVÁ MACHOVÁ, K., ZACH, J., LINHARTOVÁ, J., VYORAL, D., PETRÁK, J. Proteomic analysis of imatinib-resistant CML-T1 cells reveals calcium homeostasis as a potential therapeutic target. Oncology Reports 2016, vol. 36, no. 3, p. 1258-1268.
MACHOVÁ-POLÁKOVÁ, K., KULVAIT., V., BENEŠOVÁ, A., LINHARTOVÁ, J., KLAMOVÁ, H., JARUŠKOVÁ, M., de BENEDITTIS, C., HAFERLACH, T., BACCARINI, M., MARTINELLI, G., STOPKA, T., ERNST, T., HOCHHAUS, A., KOHLMAN, A., SOVERINI, S. Next-generation deep sequencing improves detection of BCR-ABL1 kinase domain mutations emerging under tyrosine kinase inhibitor treatment of chronic myeloid leukemia patients in chronic phase. Journal of Cancer Research and Clinical Oncology 2015, vol. 141, no. 5, p. 887-899.
JURČEK, T., RÁZGA, F., MAZANCOVÁ, P., MUSILOVÁ, M., DVOŘÁKOVÁ, D., BORSKÝ, M., ŽÁČKOVÁ, D., DOBEŠOVÁ, B., SEMERÁD, L., MAYER, J., RÁČIL, Z. Prospective analysis of low-level BCR-ABL1 T315I mutation in CD34+ cells of patients with de novo chronic myeloid leukemia. Leukemia & Lymphoma 2014, vol. 55, no. 8, p. 1915-1917.
POLÁKOVÁ, K.M., ZEMANOVÁ, K., SOUČKOVÁ, M., BROUČKOVÁ, A., KLAMOVÁ, H. Molekulární genetika v diagnostice a léč bě chronické myeloidní leukemie [Molecular genetics in the chronic myeloid leukemia diagnostics and therapy]. Vnitřní lékařství 2012, vol. 58, no. SUPPL.2, p.2S38-2S45.
RÁZGA, F., JURČEK, T., ŽÁČKOVÁ, D., DVOŘÁKOVÁ, D., TOŠKOVÁ, M., JEŽÍŠKOVÁ, I., MAYER, J., RÁČIL, Z. Role of Treatment in the Appearance and Selection of BCR-ABL1 Kinase Domain Mutations. Molecular Diagnosis & Therapy 2012, vol. 16, no. 4, p. 251-259.
RÁZGA, F., JURČEK, T., JEŽÍŠKOVÁ, I., ŽÁČKOVÁ, D., DVOŘÁKOVÁ, D., BORSKÝ, M., MAYER, J., RÁČIL, Z. Analysis of mutations in the BCR-ABL1 kinase domain, using direct sequencing detection of the T315I mutation in bone marrow CD34+cells of a patient with chronic myelogenous leukemia 6 months prior to its emergence in peripheral blood. Molecular Diagnosis & Therapy 2012, vol. 16, no. 3, p. 163-166.

back

DOUBEK, M., PALÁSEK, I., POSPÍŠIL, Z., BORSKÝ, M., KLABUSAY, M., BRYCHTOVÁ, Y., JURČEK, T., JEŽÍŠKOVÁ, I., KREJČÍ, M., DVOŘÁKOVÁ, D., MAYER, J. Detection and treatment of molecular relapse in acute myeloid leukemia with RUNX1 (AML1), CBFB, or MLL gene translocations: Frequent quantitative monitoring of molecular markers in different compartments and correlation with WT1 gene expression. Experimental Hematology 2009, vol. 37, no. 6, p. 659-672.

SKOU, A.S., JUUL-DAM, K.L., HANSEN, M., LAUSEN, B., STRATMANN, S., HOLMFELDT, L., AGGERHOLM, A., NYVOLD, C.G., OMMEN, H.B., HASLE, H. Measurable Residual Disease Monitoring of SPAG6, ST18, PRAME, and XAGE1A Expression in Peripheral Blood May Detect Imminent Relapse in Childhood Acute Myeloid Leukemia. Journal of Molecular Diagnostics 2021, vol. 23, no. 12, p. 1787-1799. DOI: 10.1016/j.jmoldx.2021.09.004
PUCKRIN, R., ATENAFU, E.G., CLAUDIO, J.O., CHAN, S., GUPTA, V., MAZE, D., McNAMARA, C., MURPHY, T., SHUH, A.C., YEE, K., SIBAI, H., MINDEN, M.D., WEI, C., STOCKLEY, T., KAMEL-REID, S., SCHIMMER, A.D. Measurable residual disease monitoring provides insufficient lead-time to prevent morphologic relapse in the majority of patients with core-binding factor acute myeloid leukemia. Haematologica 2021, vol. 106, no. 1, p. 56-63, DOI: 10.3324/haematol.2019.235721
SKOU, A-S., JUUL-DAM, K.L., OMMEN, H.B., HASLE, H. Peripheral blood molecular measurable residual disease is sufficient to identify patients with acute myeloid leukaemia with imminent clinical relapse. British Journal Of Haematology 2021, DOI: 10.1111/bjh.17449
JENTZSCH, M., BILL, M., GRIMM, J., SCHULZ, J., BEINICKE, S., HANTSCHEL, J., GOLDMANN, K., POENISH, W., FRANKE, G.N., VUCINIC, V., CROSS, M., BEHRE, G., LANGE, T., NIEDERWISER, D., SCHWIND, S. Prognostic Impact of Blood MN1 Copy Numbers Before Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia. Hemasphere 2019, vol. 3, no. 1, DOI: 10.1097/HS9.0000000000000167
EHINGER, M., PETTERSSON, L. Measurable residual disease testing for personalized treatment of acute myeloid leukemia. APMIS 2019, vol. 127, no. 5, p. 337-351.
MASHIMA, K., OH, I., IKEDA, T., TODA, Y., ITO, S., UMINO, K., MINAKATA, D., NAKANO, H., MORITA, K., YAMASAKI, R., KAWASAKI, Y., SUGIMOTO, M., YAMAMOTO, C., ASHIZAWA, M., FUJIWARA, S-I., HATANO, K., SATO, K., OMINE, K., MUROI, K., KANDA, Y. Role of Sequential Monitoring of WT1 Gene Expression in Patients With Acute Myeloid Leukemia for the Early Detection of Leukemia Relapse. Clinical Lymphoma Myeloma & Leukemia 2018, vol. 18, no. 12, p. E520-E526. doi 10.1016/j.clml.2018.07.298
JENTZSCH, M., BILL, M., GRIMM, J., SCHULZ, J., GOLDMANN, K., BEINICKE, S., HANTSCHEL, J., PONISCH, W., FRANKE, G-N., VUCINIC, V., BEHRE, G., LANGE, T., NIEDERWIESER, D., SCHWIND, S. High BAALC copy numbers in peripheral blood prior to allogeneic transplantation predict early relapse in acute myeloid leukemia patients. ONCOTARGET 2017, vol. 8, no. 50, p. 87944-87954.
YANG, H., CAO, T.T., GAO, L., WANG, L.L., ZHU, C.Y., XU, Y.Y., JING, Y., ZHU, H.Y., LV, N., YU, L. The incidence and distribution characteristics of MLL rearrangements in Chinese acute myeloid leukemia patients by multiplex nested RT-PCR. Technology and Health Care 2017, vol 25, Supplement 1, p. S259-S265.
OMMEN, H.B. Monitoring minimal residual disease in acute myeloid leukaemia: a review of the current evolving strategies. Therapeutic Advances in Hematology 2016, vol. 7, no. 1, p. 3-16.
OFRAN, Y., ROWE, J.M. Introducing minimal residual disease in acute myeloid leukemia. Current Opinion in Hematology 2015, vol. 22, no. 2, p. 139-145.
SCHWAMB, J., PALLASH, C.P. Nucleic Acids as Molecular Diagnostics in Hematopoietic Malignancies - Implications in Diagnosis, Prognosis, and Therapeutic Management. Book chapter in: KELLER, A., MEESE, E. (eds.) Nucleic Acids as Molecular Diagnostics, p. 185-200, Willey, 2014.
LIU, J., WANG, Y., XU, L-P.; LIU, D-H., QIN, Y-Z., CHANG, Y-J., LIU, K-Y., HUANG, X-J. Monitoring Mixed Lineage Leukemia Expression May Help Identify Patients with Mixed Lineage Leukemia-Rearranged Acute Leukemia Who Are at High Risk of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 2014, vol. 20, no. 7, p. 925-936.
TAKEDA, A., SHIMADA, A., HAMAMOTO, K., YOSHINO, S., NAGAI, T., FUJII, Y., YAMADA, M., NAKAMURA, Y., WATANABE, T., WATANABE, Y., YAMAMOTO, Y., SAKAKIBARA, K., ODA, M., MORISHIMA, T. Detection of RBM15-MKL1 Fusion Was Useful for Diagnosis and Monitoring of Minimal Residual Disease in Infant Acute Megakaryoblastic Leukemia. Acta Medica Okayama 2014, vol. 68, no. 2, p. 119-123.
HUAN, TX., WU, XG., BAI, ZL., CHEN, J.Y. Seed-weighted random walk ranking for cancer biomarker prioritisation: a case study in leukaemia. International Journal of Data Mining and Bioinformatics 2014, vol. 9, no. 2, p. 135-148.
PAIETTA, E, Minimal residual disease in acute myeloid leukemia: coming of age. Hematology - American Society Hematology Education Program 2012, p. 35-42, DOI: 10.1182/asheducation-2012.1.35
CAMPAN, D., BIONDI, A., VAN DONGEN, J.J.M. Minimal residual disease. Childhood Leukemias 2012. 3rd ed., 632-659 (Book Chapter)
GRAY, J.X., McMILLEN, L., MOLLEE, P., PAUL, S., LANE, S., BIRD, R., GILL, D., SAAL, R., MARLTON, P. WT1 expression as a marker of minimal residual disease predicts outcome in acute myeloid leukemia when measured post-consolidation. Leukemia Research 2012, vol. 36, no. 4, p. 453-458.
HOKLAND, P., OMMEN, H.B. Towards individualized follow-up in adult acute myeloid leukemia in remission. Blood 2011, vol. 117, no. 9, p. 2577-2584.
HUAN, TX., WU, XG., BAI, ZL., CHEN, J., Y. Seed-weighted Random Walks Ranking Method and Its application to Leukemia Cancer Biomarker Prioritizations. BIBMW: 2009 IEEE International Conference on Bioinformatics and Biomedicine Workshop. 2009, p. 217-222.
WERMKE, M., THIEDE, C., KIANI, A., EHNINGER, G., BORNHAUSER, M., PLATZBECKER, U. Successful treatment of molecular relapse in NPM1-positive AML using 5-azacytidine. Leukemia 2010, vol. 24, no. 1, p. 236-237.

CHOVANCOVÁ J., BERNARD T., STEHLIKOVÁ O., ŠÁLEK D., JANÍKOVÁ A., MAYER J., DOUBEK M. Detection of Minimal Residual Disease in Mantle Cell Lymphoma-Establishment of Novel Eight-Color Flow Cytometry Approach. Cytometry part B - Clinical Cytometry 2015. vol. 88, no. 2, p. 92-100.
RÁČIL, Z., TOSKOVÁ, M., DVOŘÁKOVÁ, D., JEŽÍŠKOVÁ, I., RÁZGA, F., BUREŠOVÁ, L., TIMILSINA, S., MAYER, J. Treatment of molecular relapse in patients with acute myeloid leukemia using clofarabine monotherapy. American Journal of Hematology 2012, vol. 87, no. 2, p. 211-213.
HORKÝ, O., MAYER, J., KABLÁSKOVÁ, L., RÁZGA, F., KREJČÍ, M., KISSOVÁ, J., BORSKÝ, M., JEŽÍŠKOVÁ, I., DVOŘÁKOVÁ, D. Increasing hematopoietic microchimerism is a reliable indicator of incipient AML relapse. International Journal of Laboratory Hematology 2011, vol. 33, no. 1, p. 57-66.
DVOŘÁKOVÁ, D., RÁČIL, Z., JEŽÍŠKOVÁ, I., PALÁSEK, I., PROTIVÁNKOVÁ, M., LENGEROVÁ, M., RÁZGA, F., MAYER, J. Monitoring of minimal residual disease in acute myeloid leukemia with frequent and rare patient-specific NPM1 mutations. American Journal of Hematology 2010, vol. 85, no. 12, p. 926-929.

back

MAYER, J., KREJČÍ, M., POSPÍŠIL, Z., DOUBEK, M, JANÍKOVÁ, A., ŽÁČKOVÁ, D., RÁČIL, Z., ŠMARDOVÁ, L., NAVRÁTIL, M., KAMELANDER, J. Successful treatment of steroid-refractory hepatitic variant of liver graft-vs-host disease with pulse cyclophosphamide. Experimental Hematology 2009, vol. 37, no. 6, p. 767-773.

CAI, Y., ALI, A., FILLER, E., BAYATI, R., TOMA, T., ZAKI, O., YAGHMOUR, G., LADHA, A., WOAN, K., TAM, E., CHAUDHARY, P.M. Case report: Pulse cyclophosphamide for treatment of multi-agent-refractory hepatic graft-versus-host disease. Frontiers in Oncology 2024, vol. 14, DOI: 10.3389/fonc.2024.1329893
STUECK, A.E., FIEL, M.I. Hepatic graft-versus-host disease: what we know, when to biopsy, and how to diagnose. Hum.Pathol. 2023, DOI: 10.1016/j.humpath.2023.07.007
ALI, R., RAMDIAL, J., ALGAZE, S., BEITINJANEH, A. The Role of Anti-Thymocyte Globulin or Alemtuzumab-Based Serotherapy in the Prophylaxis and Management of Graft-Versus-Host Disease. Biomedicines 2017, vol. 5, no. 4:10.3390/biomedicines5040067
HOCKENBERY, D.M., STRASSER, S.I., McDONALD, G.B. Gastrointestinal and Hepatic Complications. Book chapter in: STEPHEN J.F., ROBERT S.N., JOSEPH H.A., FREDERICK R. (eds.) Thomas' Hematopoietic Cell Transplantation, p. 1140-1160. Willey 2016.
KAWAHARA, Y., MORIMOTO, A., MASUZAWA, A., IKEDA, T., HAYASE, T., KASHII, Y., NOZAKI, Y., KANAI, N., MOMOI, M.Y. Successful treatment with pulse cyclophosphamide of a steroid-refractory hepatitic variant of liver acute graft-vs.-host disease in a child. Pediatric Transplantation 2012, vol. 16, no. 7, p. E315-319.
CHEN, X.-B., YANG, J., XU, M.-Q. YAN, L.N. Unsuccessful treatment of four patients with acute graft-vs-host disease after liver transplantation. World Journal of Gastroenterology 2012, vol. 18, no. 1, p. 84-89.
SCHLEUNING, M. Systemic treatment of chronic GVHD. Cellular Therapy and Transplantation 2009, vol. 2, no. 6, Article no. e.000050.01

LOCHMANOVÁ, G., JEDLIČKOVÁ, L., POTEŠIL, D., TOMANCOVÁ, A., VERNER, J., POSPÍŠILOVÁ, Š., DOUBEK, M., MAYER, J., ZDRÁHAL, Z. Potential biomarkers for early detection of acute graft-versus-host disease. Proteomics Clinical Applications 2012, vol. 6, no. 7-8, p. 351-363.
KREJČÍ, M., MAYER, J. Evaluation of Response in Hepatitic Variant of Acute Liver Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation 2010, vol. 16, no. 5, p. 705.

back

DOUBEK, M., JUNGOVÁ, A., BREJCHA, M., PANOVSKÁ, A., BRYCHTOVÁ, Y., POSPÍŠIL, Z., MAYER, J. Alemtuzumab v terapii chronické lymfocytární leukemie: retrospektivní analýza a hodnocení léčebné odpovědi podle cytogenetického rizika [Alemtuzumab in chronic lymphocytic leukemia treatment: Retrospective analysis of outcome according to cytogenetics]. Vnitřní lékařství 2009, vol. 55, no. 6, p. 549-554.

LYSÁK, D., SCHWARZ, J. Léčba chronické lymfocytární leukemie s aberací TP53. [Treatment of chronic lymphocytic Leukemia with TP53 aberrations.] Klinická onkologie 2015, vol. 28, p. 3S39-3S44.
LYSÁK, D., JINDRA, P. Vysoce riziková chronická lymfocytární leukemie - Charakteristika a léčebné možnosti [Ultra-high-risk chronic lymphocytic leukemia - Characteristics and treatment options]. Vnitřní lékařství 2013, vol. 59, no. 10, p. 887-894.
HOROVÁ, I., KOLÁČEK, J., ZELINKA, J. Kernel smoothing in MATLAB: Theory and practice of kernel smoothing. Singapore: World Scientific Publishing Co. 2012, 227 p. ISBN 978-981-4405-48-5
MOTYČKOVÁ, M., ŽÁK, P., VRBOLOVÁ, V., ANDRÝS, C., BELADA, D., MALÝ, J., SMOLEJ, L. Prognostické faktory u chronické lymfocytární leukemie [Prognostic markers in chronic lymphocytic leukemia]. Vnitřní lékařství 2011, vol. 57, no. 10, p.847-857.

FIEGL, M., STAUDER, R., STEURER, M., MIAN, M., HOPFINGER, G., BRYCHTOVÁ, Y., SKRABS, C., ZABERNIGG, A., SCHMID, F., HASLBAUR, F., WINDER, G.,WALDER, A., LANG, A., VOSKOVÁ, D., GREIL, R., MAYER, J., GASTL, G. Alemtuzumab in chronic lymphocytic leukemia: Final results of a large observational multicenter study in mostly pretreated patients. Annals of Hematology 2014, vol. 93, no. 2, p. 267-277.

back

BREJCHA, M., DOUBEK, M., CMUNT, E., SCHWARZ, J., POSPÍŠIL, Z., KOZMON, P., BRYCHTOVÁ, Y., CETKOVSKÝ, P., TRNĚNÝ, M., MAYER, J. Nové prognostické markery u chronické lymfocytárni leukemie v každodenní hematologické praxi. Analýza dat ze čtyř pracovišt' [New prognostic markers of chronic lymphocytic leukemia (CLL) in the everyday hematological practice. An analysis of data from four hematology departments]. Transfúze a hematologie dnes 2010, vol. 16, no. SUPPL.1, p. 62-66.

KREUZBERGER, N., DAMEN, J.A.A.G., TRIVELLA, M., ESTCOURT, L.J., ALDIN, A., UMLAUFF, L., VAZQUEZ-MONTES, M.D.L.A., WOLFF, R., MOONS, K.G.M., MONSEF, I., FARID FOROUTAN, F., KREUZER, K.-A., SKOETZ, N.} Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis. Cochrane Database of Systematic Reviews 2020, vol. 7, DOI: 10.1002/14651858.CD012022.pub2

back

KREJČÍ, M., MAYER, J., DOUBEK, M., BRYCHTOVÁ, Y., POSPÍŠIL, Z., RÁČIL, Z., DVOŘÁKOVÁ, D., LENGEROVÁ, M., HORKÝ, O., KOŘÍSTEK, Z., DOLEŽAL, T., VORLÍČEK, J. Clinical outcomes and direct hospital costs of reduced-intensity allogeneic transplantation in chronic myeloid leukemia. Bone Marrow Transplantation 2006, vol. 38, no. 7, p. 483-491.

ELMAKATY, I., SAGLIO, G., AL-KHABORI, M., ELSAYED, A., ELSAYED, B., ELMARASI, M., ELSABAGH, A.A., ALSHURAFA, A., ALI, E., YASSIN, M. The Contemporary Role of Hematopoietic Stem Cell Transplantation in the Management of Chronic Myeloid Leukemia: Is It the Same in All Settings? Cancers 2024, vol. 16, no. 4, DOI: 10.3390/cancers16040754
SHIMADA, H., TANIZAWA, A., KONDO, T., NAGAMURA-INOUE, T., YASUI, M., TOJO, A., MURAMATSU, H., ETO, T., DOKI, N., TANAKA, M., SATO, M., NOGUCHI, M., UCHIDA, N., TAKAHASHI, Y., SAKATA, N., ICHINOHE, T., HASHII, Y., KATO, K., ATSUTA, Y., OHASHI, T. Prognostic Factors for Outcomes of Allogeneic HSCT for Children and Adolescents/Young Adults With CML in the TKI Era. Transplantation and Cellular Therapy 2022, DOI: 10.1016/j.jtct.2022.04.011
INNES, A.J., MILOJKOVIC, D., APPERLEY, J.F. Allogeneic transplantation for CML in the TKI era: striking the right balance. Nature Reviews Clinical Oncology 2016, vol. 13, no. 2, p. 79-91.
WU, K-N., LUO, Y., LIU, L-Z., ZHAO, Y-M., HU, Y-X., TAN, Y-M., LAI, X-Y., HUANG, H. Twin Pregnancy and Childbirth after Reduced-intensity Conditioning Allogeneic Haematopoietic Stem Cell Transplantation Combined with Imatinib Mesylate for Chronic Myeloid Leukaemia: Case Report and Literature Review. Journal of International Medical Research 2012, vol. 40, no. 6, p. 2409-2415.
MATTHES-MARTIN, S., POTSCHGER, U., BARR, R., MARTIN, M., BOZTUG, H., KLINGEBIEL, T., ATTARBASCHI, A., EIBLER, W., MANN, G. Costs and Cost-Effectiveness of Allogeneic Stem Cell Transplantation in Children Are Predictable. Biology of Blood and Marrow Transplantation 2012, vol. 18, no. 10, p. 1533-1539.
TOPCUOGLU, P., ARAT, M., OZCAN, M., ARSLAN, O., ILHAN, O., BEKSAC, M., GURMAN, G. Case-matched comparison with standard versus reduced intensity conditioning regimen in chronic myeloid leukemia patients. Annals of Hematology 2012, vol. 91, no. 4, p. 577-586.
BARR, R.D. Economic evaluation of hematopoietic stem cell transplantation. Hematology 2012, vol. 17, no. SUPPL.1, p. S198-S201.
VENEPALLI, N., REZVANI, K., MIELKE, S., SAVANI, B. N. Role of allo-SCT for CML in 2010. Bone Marrow Transplantation 2010, vol. 45, no. 11, p. 1579-1586.
NIVISON-SMITH, I., BRADSTOCK, K.F., DODDS, A.J., HAWKINS, P.A., MA, D.D.F., MOORE, J.J., SIMPSON, J.M., SZER, J. Hematopoietic Stem Cell Transplantation in Australia and New Zealand, 1992-2004. Biology of Blood and Marrow Transplantation 2007, vol.13, no.8, p.905-912.
CHAKRABARTI, S., BUYCK, H.C.E. Reduced-intensity transplantation in the treatment of haematological malignancies: Current status and future-prospects. Current Stem Cell Research and Therapy 2007, vol. 2, no. 2, p. 163-188.

TOMENENDALOVÁ, J., MAYER, J., DOUBEK, M., HORKÝ, D., ŘEHÁKOVÁ, K., DOUBEK, J. Chlorambucil and fludarabine as a new pre-transplant conditioning for patients with chronic lymphocytic leukemia: Results of in vivo experiments. Veterinární medicína 2008, vol. 53, no. 10, p. 564-571
MAYER, J., ŽÁČKOVÁ, D., KLAMOVÁ, H., DOUBEK, M. Léčba chronické myeloidní leukémie - Méně běžný pohled na moderní postupy. [Therapy of chronic myeloid leukemia. Uncommon view of the modern approaches] Časopis lékařů českých 2008, vol. 147, no. 4, p. 206-210.

back

MAYER, J., KREJČÍ, M., DOUBEK, M., POSPÍŠIL, Z., BRYCHTOVÁ, Y., TOMIŠKA, M., RÁČIL, Z. Pulse cyclophosphamide for corticosteroid-refractory graft-versus-host disease. Bone Marrow Transplantation 2005, vol. 35, no. 7, p. 699-705.

KIM, D.D,H., POPRADI, G., LEPIC, K., PAULSON K., ALLAN, D., NAMPOOTHIRI, R.M., LACHANCE, S., DEOTARE, U., WHITE, J., ELEMARY, M., JAMANI, K., FRAGA, C., LEMIEUX, C., NOVITZKY-BASSO, I., LAW, A.D., KUMAR, R., WALKER, I., SHULTZ, K.R. Cell Therapy Transplant Canada (CTTC) Consensus-Based Guideline 2024 for Management and Treatment of Chronic Graft-Versus-Host Disease and Future Directions for Development. Current Oncology 2024, vol. 31, no. 3, p. 1426-1444 DOI: 10.3390/curroncol31030108
MUDDEBIHAL, A., KHURANA, A., SARDANA, K. Cyclophosphamide in a Recalcitrant Case of Nekam's Disease. Dermatology Practical & Conceptual 2023, vol. 13, no. 3, DOI: 10.5826/dpc.1303a154
WOLFF, D., FATOBENE, G., ROCHA, V., KROGER, N., FLOWERS, M.E. Steroid-refractory chronic graft-versus-host disease: treatment options and patient management. Bone Marrow Transplantation 2021, DOI: 10.1038/s41409-021-01389-5
TOUBAI, M., MAGENAU, J. Immunopathology and biology-based treatment of steroid-refractory graft-versus-host disease. Blood 2020, vol. 136, no. 4, p. 429-440.
FANTE, M.A., HOLLER, B., WEBER, D., ANGSTWURM, K., BERGLER, T., HOLLER, E., EDINGER, M., HERR, W., WERTHEIMER, T., WOLFF, D. Cyclophosphamide for salvage therapy of chronic graft-versus-host disease: a retrospective analysis. Annals of Hematology 2020, DOI: 10.1007/s00277-020-04193-1
SIMPSON, R.J., BIGLEY, A.B., SPIELMANN, G., LaVOY, E.C.Y., KUNZ, H., BOLLARD, C.M. Human cytomegalovirus infection and the immune response to exercise. Exercise Immunology Review, 2016, vol. 22, p. 8-26.
KIM, S.Y., KIM, A.R., YOON, S.Y., CHO, Y.H., LEE, M.H. Substitution of methotrexate with corticosteroid for acute graft-versus-host disease prevention in transplanted patients who develop methotrexate toxicity. Annals of Hematology 2016, vol. 95, no. 3, p. 483-491.
FIUZA-LUCES, C., GARATACHEA, N., SIMPSON, R.J., BERGER, N.A., RAMIREZ, M., LUCIA, A. Understanding graft-versus-host disease. Preliminary findings regarding the effects of exercise in affected patients. Exercise Immunology Review 2015, vol. 21, p. 80-112.
KAWAHARA, Y., MORIMOTO, A., MASUZAWA, A., IKEDA, T., HAYASE, T., KASHII, Y., NOZAKI, Y., KANAI, N., MOMOI, M.Y. Successful treatment with pulse cyclophosphamide of a steroid-refractory hepatitic variant of liver acute graft-vs.-host disease in a child. PEDIATRIC TRANSPLANTATION 2012, vol. 16, no. 7, p. E315-E319.
DIGNAN, F.L., AMROLIA, P., CLARK, A., CORNISH, J., JACKSON, G., MAHENDRA, P., SCARISBRICK, J.J., TAYLOR, P.C., SHAW, B.E., POTTER, M.N. Diagnosis and management of chronic graft-versus-host disease. British Journal of Haematology 2012, vol. 158, no. 1, p. 46-61, 10.1111/j.1365-2141.2012.09128.x.
MARTIN, P.J., INAMOTO, Y., FLOWERS, M.E.D., CARPENTER, P.A. Secondary Treatment of Acute Graft-versus-Host Disease: A Critical Review. Biology of Blood and Marrow Transplantation 2012, vol. 18, no. 7, p. 982-988.
RZEPECKI, P., GAWRONSKI, K., MLOT, B., OBORSKA, S., PIELICHOWSKI, W., WASKO-GRABOWSKA, A. Leczenie sterydoopornej ostrej choroby przeszczep przeciwko gospodarzowi. [Treatment of steroid-resistant acute graft-versus-host disease] Current Gynecologic Oncology 2011, vol. 9., no. 4, p. 253-263.
WOLFF, D., SCHLEUNING, M., VON HARSDORF, S., BACHER, U., GERBITZ, A., STADLER, M., AYUK, F., KIANI, A., SCHWERDTFEGER, R., VOGELSANG, G.B., KOBBE, G., GRAMATZKI, M., LAWITSCHKA, A., MOHTY, M., PAVLETIC, S.Z., GREINIX, H., HOLLER, E. Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation 2011, vol. 17, no. 1, p. 1-17.
BOUZAS, L.F., SILVA, M.M, TAVARES, R.C., MOREIRA, M.C.R., CORREA, M.E., FUNKE, V.A.M., VALDETARO, J., SOUZA, M.P., COLTURATO, V.A.R., Vigorito, A.C., MAUAD, M.A., MAUAD, L.M.Q. Diretrizes para o diagnóstico, classificação, profilaxia e tratamento da doença enxerto contra hospedeiro crônica. [Guidelines for the diagnosis, classification, prophylaxis and treatment of chronic graft-versus-host disease.] Revista Brasileira de Hematologia e Hemoterapia 2010, vol. 32, p. 22-39.
KNOBLER, R., KOUBA, M., POHLREICH, D. Graft-versus-host disease. In KRIEG, T., BICKERS, D.R., MIYACHI, Y. Therapy of skin diseases: A worldwide perspective on therapeutic approaches and their molecular basis. Berlin-Heidelberg: Springer-Verlag, 2010, 766 p. ISBN 978-354078813-3. (Book chapter)
JACOBSON, P., A., HUANG, J. Y., WU, J., KIM, M., LOGAN, B., ALOUSI, A., GRIMLEY, M., BOLANOS-MEADE, J., H, V., LEVINE, J., E., WEISDORF, D. Mycophenolate Pharmacokinetics and Association with Response to Acute Graft-versus-Host Disease Treatment from the Blood and Marrow Transplant Clinical Trials Network. Biology of Blood and Marrow Transplantation 2010, vol. 16, no. 3, p. 421-429.
SCHLEUNING, M. Systemic treatment of chronic GVHD. Cellular Therapy and Transplantation 2009, vol. 2, no. 6, article number e.000050.01
MARTIN, P.J., PAVLETIC, S.Z. Biology and management of chronic graft-versus-host disease. Cancer Treatment and Research 2009, vol. 144, p. 277-298.
PAVLETIC, S.Z., VOGELSANG, G.B. Chronic Graft-versus-Host Disease: Clinical Manifestations and Therapy. In APPELBAUM, F.R., FORMAN, S.J., NEGRIN, R.S., BLUME, K.G. Thomas' Hematopoietic Cell Transplantation: Stem Cell Transplantation, Fourth Edition 2009, J.Willey and Sons, ISBN 978-140515348-5, p. 1304-1324 (Book chapter).
ARORA, M. Therapy of chronic graft-versus-host disease. Best Practice and Research: Clinical Haematology 2008, vol. 21, no. 2, p. 271-279.
KIM, S. S. Treatment options in steroid-refractory acute graft-versus-host disease following hematopoietic stem cell transplantation. The Annals of Pharmacotherapy 2007, vol. 41, p. 1436-1444.
FRASER, C. J., SCOTT BAKER, K. The management and outcome of chronic graft-versus-host disease. British Journal of Haematology 2007, vol. 138, no. 2, p. 131-145.
BOLANOS-MEADE, J. Update on the management of acute graft-versus-host disease. Current Opinion in Oncology 2006, vol. 18, no. 2, p. 120-125.
CUTLER, J., ANTIN, J., H. Chronic graft-versus-host disease. Current Opinion in Oncology 2006, vol. 18, no. 2, p. 126-131.

KREJČÍ, M., MAYER, J. Evaluation of Response in Hepatitic Variant of Acute Liver Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation 2010, vol. 16, no. 5, p. 705.
MAYER, J., KREJČÍ, M., POSPÍŠIL, Z., DOUBEK, M; JANÍKOVÁ, A., ŽÁČKOVÁ, D., RÁČIL, Z., ŠMARDOVÁ, L., NAVRÁTIL, M., KAMELANDER, J. Successful treatment of steroid-refractory hepatitic variant of liver graft-vs-host disease with pulse cyclophosphamide. Experimental Hematology 2009, vol. 37, no. 6, p. 767-773.
MAYER, J., CETKOVSKÝ, P., KREJČÍ, M. Steroid-rezistentní akutní reakce štěpu proti hostiteli (GVHD) [Steroid-refractory acute graft-versus-host disease (GVHD)]. Transfúze a hematologie dnes 2007, vol. 13, no. 4, p. 271-279.
KREJČÍ, M., DOUBEK, M., BUCHLER, T., BRYCHTOVÁ, Y., VORLÍČEK, J., MAYER, J. Mycophenolate mofetil for the treatment of acute and chronic steroid-refractory graft-versus-host disease. Annals of Hematology 2005, vol. 84, no. 10, p. 681-685.

back

MAYER, J., POSPÍŠIL, Z., KOŘÍSTEK, Z. Peripheral blood stem cells - Mathematical model of peripheral blood stem cell harvest kinetics. Bone Marrow Transplantation 2003, vol. 32, no. 8, p. 749-757.

CASTILLO-ALEMAN, Y.M. Crude collection efficiency of CD34+ hematopoietic stem cell apheresis. Journal of Clinical Apheresis2023, DOI: 10.1002/jca.22096

CHEN, J., GOSS, C., AVECILLA, S.T., HONG, H., WALSH, E., WUEST, D., MASLAK, P., PESSIN, M.S. Evaluation of peripheral blood mononuclear cell collection by leukapheresis. Transfusion 2019, vol. 59, no. 6, p. 1765-1772.

VERLINDEN, A., VAN DE VELDE, A., VERPOOTEN, G.A., VAN DOORN, K.J. Determining Factors Predictive of CD34+Cell Collection Efficiency in an Effort to Avoid Extended and Repeated Apheresis Sessions. Journal of Clinical Apheresis 2013, vol. 28, no. 6, p. 404-410.

BRAUNINGER, S., BIALLECK, H., THORAUSCH, K., FELT, T., SEIFRIED, E., BONIG, H. Allogeneic donor peripheral blood "stem cell" apheresis: prospective comparison of two apheresis systems. Transfusion 2012, vol. 52, no. 5, p. 1137-1145.

CHEN, X-X., WANG, Z-M., LUO, X-S., XU, D-D., LI, X., LEI, M.-Q. Best time for mobilization and collection of peripheral blood stem cell from healthy donors. Journal of Clinical Rehabilitative Tissue Engineering Research 2010, vol. 14, no. 6, p.1068-1071.

YANG Shen-Miao, LIU Kai-Yan, LU Dao-Pei. Comparison of the Effect of Cobe Spectra and Fenwal CS 3000 Plus Blood Cell Separators in Collection of Peripheral Blood Stem Cell Components. Journal of Experimental Hematology 2005, vol. 13, no. 2, p. 245-249. URL
WANG Cun-bang, OU Ying-xian, BAI Hai et al. Dynamic changes of CD34+ cell and T lymphocyte subsets in bone marrow or peripheral blood during peripheral blood stem cell mobilization. Medical Journal of National Defending Forces in Northwest China 2006, vol. 27, no. 3, p. 190-192.

back

OBOŘILOVÁ, A., MAYER, J., POSPÍŠIL, Z., KOŘÍSTEK, Z. Symptomatic intravenous antipyretic therapy: Efficacy of metamizol, diclofenac, and propacetamol. Journal of Pain and Symptom Management 2002, vol. 24, no. 6, p. 608-615.

MEHMOOD, K.T., AL-BALDAWI, S., SALAZAR, G.Z., ZUÑIGA, D., BALASUBRAMANIAN, S. Antipyretic Use in Noncritically Ill Patients With Fever: A Review. Cureus Journal of Medical Science 2024, vol. 16, no. 1, art.no. e51943, DOI: 10.7759/cureus.51943
AGNO, K-C., YANG, K., BYUN, S-H., OH, S., LEE, S., KIM, H., KIM, K., CHO, S., JEONG, W-I. JEONG, J-W. A temperature-responsive intravenous needle that irreversibly softens on insertion. Nature Biomedical Engineering 2023, DOI: 10.1038/s41551-023-01116-z
SOLÁR, P., JOUKAL, M., ŠILAR, Č., JANČÁLEK, R. Impact of analgesic regimen on patient outcome following subarachnoid hemorrhage: positive adjuvant effects of metamizole. British Journal of Neurosurgery 2022, DOI: 10.1080/02688697.2022.2151563
ITO, H. Antibiotics in end-of-life care: What is the driving factor? Infectious Diseases Now 2021, vol. 51, no. 8, p. 688-688, DOI: 10.1016/j.idnow.2021.07.003
SALVAGNO, G.L., HENRY, B.M. LIPPI, G. Lower nasopharyngeal viral load in young SARS-CoV-2-positive subjects. Infectious Diseases Now 2021, vol. 51, no. 8, p. 686-688, DOI: 10.1016/j.idnow.2021.09.004
CAN, O., KIYAN, G.S., YALCINLI, S. Comparison of intravenous ibuprofen and paracetamol in the treatment of fever: A randomized double-blind study. Americah Journal of Emergency Medicine 2021, vol. 46, p. 102-106, DOI: 10.1016/j.ajem.2021.02.057
MORRESEY, P.R., WHITE, G.W., POOLE, H.M., HU, T.H., YIN, M., SUNDMAN, E.A. Randomized blinded controlled trial of dipyrone as a treatment for pyrexia in horses. American Journal of Veterinary Research 2019, vol. 80, no. 3, p. 294-299.
ROY, S., SIMALTI, A.K. Comparison of Antipyretic Efficacy of Intravenous (IV) Acetaminophen versus Oral (PO) Acetaminophen in the Management of Fever in Children. Indian Journal of Pediatrics 2018, vol. 85, no. 1, p. 1-4.
ZASOWSKA-NOWAK, A., CIALKOWSKA-RYSZ, A. Neoplastic fever. Medycyna paliatywna-Palliative Medicine 2017, vol. 9, no. 3, p. 127-132.
KRZYZAK-JANKOWICZ, M., JANKOWICZ, R. Metamizol i paracetamol -- Leki podobne, ale nie takie same. [Metamizole and paracetamol -- Similar but not the same drugs.] Medycyna Paliatywna w Praktyce 2015, vol. 9, no. 2, p. 59-65.
BUSHUVEN, S., HEISE, D., BOLBRINKER, J. Diclofenac up2date - Teil 1: Die Pharmakologie und der Vergleich mit anderen Medikamenten [Diclofenac up2date - Part 1: Pharmacology and comparison with other drugs]. Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie 2014, vol. 49, no. 10, p. 588-598.
AMES, N.J., PENG, C., POWERS, J.H., LEIDY, N.K., MILLER-DAVIS, C., ROSENBERG, A., VanRADEN, M., WALLEN, G.R. Beyond intuition: Patient fever symptom experience. Journal of Pain and Symptom Management 2013, vol. 46, no. 6, p. 807-816.
PARAMBA, F.C., NAUSHAD, V.A., PURAYIL, I., MOHAMMED, O.H., CHANDRA, P. Randomized controlled study of the antipyretic efficacy of oral paracetamol, intravenous paracetamol, and intramuscular diclofenac in patients presenting with fever to the emergency department. Therapeutics and Clinical Risk Management 2013, vol. 9, p. 371-376, doi: 10.2147/TCRM.S45802
NIKOLOVA, I., PETKOVA, V., TENCHEVA, J., BENBASAT, N., VOINIKOV, J., DANCHEV, N. Metamizole: A review profile of a well-known "forgotten" drug. Part II: Clinical profile. Biotechnology & Biotechnological Equipment 2013,vol. 27, no. 2, p. 3605-3619.
VERA, P., ZAPATA, L., GICH, I., MANCEBO, J., BETBESE, A.J. Hemodynamic and antipyretic effects of paracetamol, metamizol and dexketoprofen in critical patients. MEDICINA INTENSIVA 2012, vol. 36, no. 9, p. 619-625.
GHERMAN-IONICA, N., BOLOGA, R., COCU, S., CRISTEA, C., DIRZU, D., HAGAU, N. Proposal for use of two concentrations for metamizol to intradermal testing. FARMACIA 2011, vol. 59, no. 4, p. 578-589.
ALTUN, I., CINAR, N.D., WALSH, A. Psychometric properties of the parents' fever management scale in a Turkish population. HEALTHMED 2011, vol. 5, no. 3, p. 567-575.
CORLEY, G., RAWLS, S.,M. Opioid, cannabinoid CB1 and NOP receptors do not mediate APAP-induced hypothermia in rats. Pharmacology Biochemistry and Behavior 2009, vol. 92, no. 3, p. 503-507.
CORMIO, M., CITERIO, G. Continuous low dose diclofenac sodium infusion to control fever in neurosurgical critical care. Neurocritical Care 2007, vol. 6, no. 2, p. 82-89.
LANDWEHR, S., KIENCKE, P., GIESECKE, T., EGGERT, D., THUMANN, G., KAMPE, S. A comparison between IV paracetamol and IV metamizol for postoperative analgesia after retinal surgery. Current Medical Research and Opinion 2005, vol. 21, no. 10, p. 1569-1575.
BELL, D., D., BRINDLEY, P., G., FORREST, D., et al. Management following resuscitation from cardiac arrest: recommendations from the 2003 Rocky Mountain Critical Care Conference. Canadian Journal of Anaesthesia-Journal Canadien d'Anesthesie 2005, vol. 52, no. 3, p. 309-322.
BARCIA, E., MARTIN, A., AZUARA, M., L., et al. Influence of medium and temperature on the hydrolysis kinetics of propacetamol hydrochloride: Determination using derivative spectrophotometry. Chemical and Pharmaceutical Bulletin 2005, vol. 53, no. 3, p. 277-280.
AYOUB, S., S., BOTTING, R., M., GOORHA, S., COLVILLE-NASH, P., R., WILLOUGHBY, D., A., BALLOU, L., R. Acetaminophen-induced hypothermia in mice is mediated by a prostaglandin endoperoxide synthase 1 gene-derived protein. Proceedings of the National Academy of Sciences of the U.S.A 2004, vol. 101, no. 30, p. 11165-11169.
DROBNIK, L. Metamizol - Lek ciagle nowoczesny [Metamizol - A drug which is still modern]. Anestezjologia Intensywna 2004, vol. 36, no. 2, p. 135-142.
YILMAZ, H., L., ALPARSLAN, N., YILDIZDAS, D., et al. Intramuscular dipyrone versus oral ibuprofen or nimesulide for reduction of fever in the outpatient setting. Clinical Drug Investigation 2003, vol. 23, no. 8, p. 519-526.
ACOSTA, A., M., MORALES, L., V., HERRERA, O., G., MOLERO, G., R., LLANDERAS, R., C. Utilizacion del propacetamol en un hospital de tercer nivel. Actuaciones derivadas de su estudio. [Use of propacetamol in a third-level hospital]. Atencion Farmaceutica 2003, vol. 5, no. 6, p. 352-360.

back

MAYER, J., KOŘÍSTEK, Z., KRAHULOVÁ, M., POSPÍŠIL, Z., DOUBEK, M., KLABUSAY, M., BRYCHTOVÁ, Y., HOFFOVÁ, V., ČERŇANSKÁ, J., KREJČÍ, M., VORLÍČEK, J. Odběr transplantátů periferních kmenových buněk krvetvorby u dobrovolných dárců - sourozenců nemocných. [Collection of transplants of peripheral haematopoietic stem cells from voluntary donors - patients siblings.] Vnitřní lékařství. 2001, vol. 47, Supplementum, p. 15-28.

KLABUSAY, M., SUKOVÁ, V., KOŘÍTEK, Z., MAYER, J., VORLÍČEK, J. Analýza fenotypu a kinetiky subpopulací CD34+ buněk a lymfocytů dárců periferních hematopoetických kmenových buněk pro alogenní transplantace [Phenotype and kinetics analysis of the CD34+ cell subpopulations and lymphocytes of donors of the peripheral haematopoietic stem cells for the allogeneic transplantation]. Časopis lékařů českých 2003, vol. 142, no. 7, p. 410-416.

back

HOROVÁ, I., POSPÍŠIL, Z., ZELINKA, J. Hazard function for cancer patients and cancer cell dynamics. Journal of Theoretical Biology. 2009, vol. 258, no. 3, p. 437-443.

LIU, F., ZHOU, Z.F., AN, Y., YU, Y., WU, R.X., YIN, Y., XUE, Y., CHEN, F-M. Effects of cathepsin K on Emdogain-induced hard tissue formation by human periodontal ligament stem cells. Journal of Tissue Engineering and Regenerative Medicine 2017, vol. 11, no. 10, p. 2922-2934.
SABATINO, G., FRANGOPOL, D.M., DONG, Y. Life cycle utility-informed maintenance planning based on lifetime functions: optimum balancing of cost, failure consequences and performance benefit. Structure and Infrastructure Engineering 2013, vol. 12, no. 7, p. 830-847, DOI: 10.1080/15732479.2015.1064968
BARONE, G., FRANGOPOL, D.M. Hazard-Based Optimum Lifetime Inspection and Repair Planning for Deteriorating Structures. Journal of Structural Engineering 2013, vol. 139, no. 12 DOI: 10.1061/(ASCE)ST.1943-541X.0000810.
DOS SANTOS, R.V., DA SILVA, L.M. The noise and the KISS in the cancer stem cells niche. Journal of Theoretical Biology. 2013, vol. 335, no. 21 p. 79-87.

HOROVÁ, I., KOLÁČEK, J., ZELINKA, J. Kernel smoothing in MATLAB: Theory and practice of kernel smoothing. Singapore: World Scientific Publishing Co. 2012, 227 p. ISBN 978-981-4405-48-5

back

DOŠLÝ, O., POSPÍŠIL, Z. Hyperbolic transformation and hyperbolic difference systems. Fasciculi Math. 2001, no. 32, p. 26-48.

DOŠLÝ, O., ELYSEEVA, J., ŠIMON HILSCHER, R. Symplectic Difference Systems: Oscillation and Spectral Theory. Birkhäuser/Springer, 2019. ISBN 978-3-030-19372-0.

back

POSPÍŠIL, Z. Hyperbolic sine and cosine functions on measure chains. Nonlin. Anal. TMA. 2001, vol. 47, no. 2, p. 861-872.

BOHNER, M., GEORGIEV, S.G. Multivariable dynamic calculus on time scales. Heidelberg: Springer 2017. 603 p. ISBN 978-3-319-47620-9
HILSCHER, R., ZEMÁNEK, P. Trigonometric and Hyperbolic Systems on Time Scales. Dynamic Systems and Applications 2009, vol. 18, no. 3-4, p. 483-505.
BOHNER, M., PETERSON, A. Dynamic Equations on Time Scales. An Introduction with Applications. Boston, Basel, Berlin: Birkhäuser, 2001. 358 p. ISBN 0-8176-4225-0.

back

POSPÍŠIL, Z. An inverse problem for matrix trigonometric and hyperbolic functions on measure chains. BARTUŠEK, M., DOŠLÝ, O. (eds.) Colloquium on Differential and Difference Equations, CDDE 2002. Brno, Czech Republic, September 4-6, 2002. Proceedings, p. 205-211.

HILSCHER, R., ZEMÁNEK, P. Trigonometric and Hyperbolic Systems on Time Scales. Dynamic Systems and Applications 2009, vol. 18, no. 3-4, p. 483-505.

back

MAYER, J., POSPÍŠIL, Z., KOŘÍSTEK, Z. Mathematical model of peripheral blood progenitor cell mobilization and harvest: theoretical considerations and clinical applications. 6th Annual Meeting of the European Haematology Association. Frankfurt, Germany, June 21-24, 2001. The Hematology Journal. 2001, vol. Suppl. I - Abstracts, p. 208.

MAYER, J., POSPÍŠIL, Z., KOŘÍSTEK, Z. Peripheral Blood Stem Cells. Mathematical model of peripheral blood stem cell harvest kinetics. Bone Marrow Transplantation 2003, vol. 32, no. 8, p. 749-757.

back

POSPÍŠIL, Z. Remark on the dissipativity of an n prey-one predator system. Math. Biosci. 1996, vol. 131, p. 173-183.

GYLLENBERG, M., OSIPOV, A. V. Types of dynamic behavior in the Hanski-Henttonen model. Diff. Equat. 1999, vol. 35, no. 7, p. 888-895.
GYLLENBERG, M., OSIPOV, A. V. Limit cycles in the two-dimensional May problem. Diff. Equat. 1999, vol. 35, no. 6, p. 733-738.
OSIPOV, A. V. On the dissipativity and the degeneration conditions in the ecological HHW-model. Diff. Equat. 1997, vol. 33, no. 5, p. 661-666.

back

OBOŘILOVÁ, A., MAYER, J., POSPÍŠIL, Z., KOŘÍSTEK, Z., VORLÍČEK, J., HAVRANOVÁ, J. Symptomatická parenterální antipyretická léčba u onkologicky nemocných - srovnání metamizolu, diclofenacu a propacetamolu. [Symptomatic intravenous antipyretic therapy in cancer patients - comparison of metamizol, diclofenac and propacetamol.] Klinická onkologie. 1999, vol. 12, no. 6, p. 200-205.

AYOUB, S.S., BOTTING, R.M., GOORHA, S., COLVILLE-NASH, P.R., WILLOUGHBY, D.A., BALLOU, L.R. Acetaminophen-induced hypothermia in mice is mediated by a prostaglandin endoperoxide synthase 1 gene-derived protein. Proceedings of the National Academy of Sciences of the United States of America 2004, vol.101, no.30, p.11165-11169.
BAKIR, B., BELGE, F., BELGE, A., TUTUNCU, M., OZEN, S., DILEK, I. Metamizol induced anaemia in dogs. Indian Veterinary Journal 2003, vol.80, no.9, p.857-859.

back

MAYER, J., KOŘÍSTEK, Z., POSPÍŠIL, Z., VÁŠOVÁ, I., ADAM, Z., HÁJEK, R., KREJČÍ, M., KRÁL, Z., NAVRÁTIL, M., VORLÍČEK, J., BOURKOVÁ, L., MATÝŠKOVÁ, M., ADLER, J., VINKLÁRKOVÁ, J., KLABUSAY, M., KOUTNÁ, I., HOFFOVÁ, V., SCHMITZOVÁ, D., JANOVSKÁ, E. Kinetika obnovy krvetvorby po vysokodávkované chemoterapii a autologní transplantaci periferních kmenových buněk. [Engraftment kinetics after high-dose chemotherapy and autologous Peripheral stem cell transplantation.] Čas. lék. čes. 1999, vol, 138, no, 6, p, 170-177.

KLABUSAY, M., LYSÁK, D., HRABČÁKOVÁ, V., NAVRÁTIL , M., ČOUPEK, P., MAYER, J. Vliv typu růstového faktoru na fenotyp subpopulací a kinetiku CD34+ buněk v periferní krvi a štěpech periferních kmenových buněk pacientů s non-hodgkinskými lymfomy indikovaný k autologní transplantaci krvetvorby [Effect of growth factor on the phenotype of subpopulations and on the kinetics of CD34+ cells in the peripheral blood and in grafts of peripheral stem cells in patients with non-Hodgkin's lymphoma indicated for autologous peripheral blood stem cell transplantation]. Časopis lékařů českých 2008, vol. 147, no. 6, p. 319-324.
KLABUSAY, M., SUKOVÁ, V., KOŘÍSTEK, Z., MAYER, J., VORLÍČEK, J. Subpopulace CD34+ buněk a jejich význam pro přihojení štěpu u příbuzenských alogenních transplantací periferní kmenových buněk. [The subpopulation of CD34+ cells and their importance in the healing of grafts in family-related allogenic transplants of peripheral stem cells]. Vnitřní lékařství 2007, vol. 53, no. 6, p. 646-651.
KLABUSAY, M., SUKOVÁ, V., KOŘÍSTEK, Z., MAYER, J., VORLÍČEK,J. Subpopulace CD34+ buněk a jejich význam pro přihojení štěpu u Analýza fenotypu a kinetiky subpopulací CD34+ buněk a lymfocytů dárců periferních hematopoetických kmenových buněk pro alogenní transplantace [Phenotype and kinetics analysis of the CD34+ cell subpopulations and lymphocytes of donors of the peripheral haematopoietic stem cells for the allogeneic transplantation]. Časopis lékařů českých 2003, vol. 142, no. 7, p. 410-416.
MAYER, J., STARÝ, J. et al. Leukémie. [Leukemia.] Praha: GRADA Publishing spol. s r. o., 2002. 357 p. ISBN 80-7169-991-8
KOŘÍSTEK, Z., ŠTĚRBA, J., MAYER, J., NAVRÁTIL, M. Odběr periferních kmenových buněk u dětí s hmotností pod 40 kg [Peripheral blood stem cell collection in children with a body-weight under 40 kg]. Česko-slovenská pediatrie 2001, vol. 56, no. 10, p. 568-574.

back

MAYER, J., POSPÍŠIL, Z. Mechanismus sedimentace erytrocytů. Víme dnes více než Robin Fahreus? [Mechanism of red cell sedimentation. Do we know more than Robin Fahreus?] Vnitřní lékařství. 1993, vol. 39, no. 6, p. 604-612.

KONDAKOV, S.E., MEL'NIKOV, M.YA., FEDORENKO, K.G., PROKOPTSEVA, O.S. Metrological approaches to drug development. Fast screening using universal biosensors at the stage of drug development. Russian Journal of General Chemistry 2012, vol. 82, no. 3, p. 535-544.
VOEIKOV, V.L., DMITRIEV, A.Y. Biophysical mechanisms of erythrocyte sedimentation reaction. Biofizika. 1998, vol. 43, no. 4, p. 575-579.
KONDAKOV, S.E., VOEIKOV, V.L., GURFINKEL, Y.I., DMITRIEV, A.Yu. Dynamics of erythrocyte sedimentation rate as a new diagnostic tool. Proceedings of SPIE - The International Society for Optical Engineering 3252 1998, p. 54-61.
VOEIKOV, V.L. Physical-chemical and physiological aspects of erythrocytes sedimentation reaction. Uspekhi Fiziologicheskikh Nauk 1998, vol. 29, no. 4, p. 69-73.

KŘIVANOVÁ, A., ADAM, Z., MAYER, J., HUSA, P., FOJTÍK, Z., SKŘIČKOVÁ, J., ŘEHÁK, Z., VORLÍČEK, J. Teplota nejasné etiologie: Příčiny a diagnostický postup [Fever of unknown origin - Etiology and diagnostic algorithm]. Vnitřní lékařství 2007, vol. 53, no. 2, p. 169-178.
ADAM, Z., VORLÍČEK, J. et al. Hematologie II. Přehled maligních hematologických nemocí. [HAEMATOLOGY II. A survey of malign haematolological diseases] Praha: GRADA Publishing spol. s r. o. and Avicenum 2001. 680 p.

back

MAYER, J., POSPÍŠIL, Z., LITZMAN J. The mechanism of erythrocyte sedimentation in Westergren's examination. Biorheology. 1992, vol. 29, no. 2-3, p. 261-271.

HIGUCHI, M., WATANABE, N. Determination of the erythrocyte sedimentation rate using the hematocrit-corrected aggregation index and mean corpuscular volume. Journal of Clinical Laboratory Analysis 2023, DOI: 10.1002/jcla.24877
MEHRI, R., MAVRIPLIS, C., FENECH, M. Design of a Microfluidic System for Red Blood Cell Aggregation Investigation. Journal of Biomechanical Engineering-Transactions of the ASME. 2014, vol. 136, no. 6, article no. 064501, DOI: 10.1115/1.4027351
BASKURT, O.K., UYUKLU, M., OZDEM, S., MEISELMAN, H.J. Measurement of red blood cell aggregation in disposable capillary tubes. Clinical Hemorheology and Microcirculation. 2011, vol. 47, no. 4, p. 295-305.
STEINVIL, A., SHAPIRA, I., ARBEL, Y., JUSTO, D., BERLINER, S., ROGOWSKI, O. Determinants of the erythrocyte sedimentation rate in the era of microinflammation : Excluding subjects with elevated C-reactive protein levels. American Journal of Clinical Pathology 2008, vol. 129, no. 3, p. 486-491.
YOSHIKOSHI, A., SAKANISHI, A., TOYAMA, Y. A digital sedimentator for measuring erythrocyte sedimentation rate using a linear image sensor. Review of Scientific Instruments. 2004, vol. 75, no. 11, p. 4379-4382.
HOLLEY, L., WOODLAND, N., HUNG, W.T., CORDATOS, K., REUBEN, A. Influence of fibrinogen and haematocrit on erythrocyte sedimentation kinetics. Biorheology. 1999, vol. 36, no. 4, p. 287-297.
VOEIKOV, V.L., DMITRIEV, A.Y. Biophysical mechanisms of erythrocyte sedimentation reaction. Biofizika. 1998, vol. 43, no. 4, p. 575-579.
CRUZ, J.M., GARCIA-DIEGO, F.J. Dielectrophoretic motion of oblate spheroidal particles. Measurments of motion of red blood cells using the Stokes method. J. Phys. D-Appl. Phys. 1998, vol. 31. no. 14, p. 1745-1751.
PRIBUSH, A., MEYERSTEIN, D., MEYERSTEIN, N. Conductometric study of erythrocytes during centrifugation. 2. Erythrocyte deformability. BBA - Lipid. Met. 1995, vol. 1256, no. 2, p. 194-200.
PRIBUSH, A., MEYERSTEIN, D., MEYERSTEIN, N. Conductometric study of erythrocytes during centrifugation. 1. Size distribution of erythrocytes. BBA - Lipid. Met. 1995, vol. 1256, no. 2, p. 187-193.

back

HLUCHÝ M., POSPÍŠIL Z. Damage and economic injury level of eriophyid and tetranychid mites on grapes in Czechoslovakia. Exp. Appl. Acarol. 1992, vol. 14, p. 95-106.

REIFF, J.M., PENNINGTON, T., KOLB, S., THEISS, K., ALAKINA, E., EHRINGER, M., MASON, P., SHRESTHA, R., ENTLING, M.H., HOFFMANN, C. Consistent benefits of fungicide reduction on arthropod predators and predation rates in viticulture: a five-year experiment. Biocontrol 2023, vol. 68, no. 5, p. 495-509.
KHEDERI, S.J., KHANJANI, M., GHOLAMI, M., de LILLO, E. Impact of the erineum strain of Colomerus vitis (Acari: Eriophyidae) on the development of plants of grapevine cultivars of Iran. Exp. Appl. Acarol. 2018, vol. 74, no. 4, p. 347-363.
VACANTE, V. The Handbook of Mites of Economic Plants Identification, Bio-ecology and Control. Oxon: Cabi Publishing, 2016. ISBN 978-1-84593-994-6
LEE, S.K., IM, J.S., JUNG, J.K., KIM, D-H., LEE, J.H. Flower and leaf damage of grapevines caused by the grape rust mite, Calepitrimerus vitis (Nalepa). Journal of Asia-Pacific Entomology 2015, vol. 18, no. 1, p. 51-54.
SCHREINER, P.R., SKINKIS, P.A., DREVES, A.J. A Rapid Method to Assess Grape Rust Mites on Leaves and Observations from Case Studies in Western Oregon Vineyards. Horttechnology 2014, vol. 24, no. 1, p. 38-47.
SIQUEIRA, P.R.E., BOTTON, M., KOHN, R.G., GRUTZMACHER, A.D., PERES, G.S. Population dynamics of Calepitrimerus vitis (Nalepa) (Acari: Eriophyidae) in different grapevine cultivars in the Campanha region of Rio Grande Do Sul. Revista Brasileira de Fruticultura 2013, vol. 35, no. 2, p. 446-453.
DUSO, C., POZZEBON, A., KREITER, S., TIXIER, M.S., CANDOLFI, M. Management of phytophagous mites in European vineyards. In BOSTANIAN, N.J., VINCENT, C., ISAACS, R. (Eds.) Arthropod Management in Vineyards: Pests, Approaches, and Future Directions 2012, Springer Netherlands, ISBN 978-94-007-4032-7, p. 191-217 (Book chapter).
SIQUEIRA, P.R.E., GRUTZMACHER, A.D., DA CUNHA U.S., KOHN, R.G., KOHN, E.T. Effect of pesticide on Calepitrimerus vitis (Nalepa, 1905) (Acari: Eriophyidae) in Campanha region from the State of Rio Grande Do Sul, Brazil. Revista Brasileira de Fruticultura 2012, vol. 34, no. 1, p. 84-92.
SIQUEIRA, P.R.E., GRUTZMACHER, A.D., BOTTON, M., KOHN, R.G. Populational fluctuation of the grape rust mite in commercial vineyard in Candiota, Rio Grande do Sul State, with different sampling methods. Ciencia Rural 2011, vol. 41, no. 9, p. 1489-1495.
WALTON, V.M., DREVES, A.J., COOP, L.B., JONES, G.V., SKINKIS, P.A. Developmental Parameters and Seasonal Phenology of Calepitrimerus vitis (Acari: Eriophyidae) in Wine Grapes of Western Oregon. Environmental Entomology 2010, vol. 39, no. 6, p. 2006-2016.
WALTON, V.M., DREVES, A.J., GENT, D.H., JAMES, D.G., MARTIN, R.R., CHAMBERS, U., SKINKIS, P.A. Relationship between rust mites Calepitrimerus vitis (Nalepa), bud mites Colomerus vitis (Pagenstecher) (Acari: Eriophyidae) and short shoot syndrome in Oregon vineyards. International Journal of Acarology 2007, vol. 33, no. 4, p. 307-318.
PARK, Y.-L., LEE, J.-H. Seasonal dynamics of economic injury levels for Tetranychus urticae Koch (Acari, Tetranychidae) on Cucumis sativus L. Journal of Applied Entomology 2007, vol. 131, no. 8, p. 588-592.
BERNARD, M.B., HORNE, P., HOFFMANN, A. A. Eriophyoid mite damage in Vitis vinifera (grapevine) in Australia: Calepitrimerus vitis and Colomerus vitis (Acari: Eriophyidae) as the common cause of the widespread 'Restricted Spring Growth' syndrome. Exp. Appl. Acarol. 2005, vol. 35, no. 1-2, p. 83-109.
BAHADIROGLU, C., AVGIN, S. Experimential infestation and seasonal variations in density of Eriophyes vitis Pgst. (Acarina : Eriophyidae) in Turkey. Consequences on earliest treatment. Acarologia 2003, vol. 43, no. 3, p. 261-265.
ŽIŽKA, Z., PELC, R., JIZBA, J., KANDYBIN, N., V., SERGEEVA, M., V. In Situ Assessment at Subcellular Level of the Effects of Macrotetrolide Insecticides on Mites by Electron Microscopy and X-Ray Microanalysis. Pesticide Biochemistry and Physiology 1997, vol. 58, no. 3, p. 165-172.
DUSO, C., DeLILO, E. 3.2.5 Grape. World Crop Pests 1996, vol. 6, Issue Eriophyoid Mites Their Biology, Natural Enemies and Control, p. 571-582.

HLUCHÝ, M. Studies on controlling the wine blister mite calepitrimerus vitis Nal. (Acari, Eriophyidae) by means of the predator mite typhlodromus pyri Scheut. (Acari, Phytoseiidae). J. Appl. Entomol. 1993, vol. 116, no. 5, p. 449-458.

back

HLUCHÝ, M., POSPÍŠIL, Z., ZACHARDA, M. Phytophagous and predatory mites (Acari: Tetranychidae, Eriophyidae, Phytoseiidae, Stigmaeidae) in South Moravian vineyards, Czechoslovakia, treated with various types of chemicals. Exp. Appl. Acarol. 1991, vol. 13, p. 41-52.

MÖTH, S., RICHART-CERVERA, S., COMSA, M., HERRERA, R.A., HOFMANN, C., KOLB, S., POPESCU, D., REIFF, j.M., RUSCH, A., TOLLE, P., WALZER, A., WINTER, S. Local management and landscape composition affect predatory mites in European wine-growing regions. Agriculture, Ecosystems & Environment 2023, vol. 344. DOI: 10.1016/j.agee.2022.108292
ALAZZAZY, M. Biological performance of the predatory mite Neoseiulus barkeri Hughes (Phytoseiidae): a candidate for controlling of three mite species infesting grape trees. Vitis 2021, vol. 60, no. 1, p. 11-20.
LIAO, J-R., HO, C-C., KO, C-C. Predatory mites (Acari: Mesostigmata: Phytoseiidae) intercepted from samples imported to Taiwan, with description of a new species. Zootaxa 2021, vol. 4927, no. 3, DOI: 10.11646/zootaxa.4927.3.1
MÖTH, S., WALZER, A., REDL, M., PETROVIĆ, B., HOFFMANN, Ch., WINTER, S. Unexpected Effects of Local Management and Landscape Composition on Predatory Mites and Their Food Resources in Vineyards. Insects 2021, vol. 12, no. 2, DOI: 10.3390/insects12020180
AL-AZZAZY, MAHMOUD M., ALHEWAIRINI, SALEH S. An Alternative Control Strategy for Grape Erineum Mites. Pakistan Journal of Agricultural Sciences 2020, vol. 57, no. 2, p. 609-614.
SCHMIDT-JEFFRIS, R.A., BEERS, E.H. Potential impacts of orchard pesticides on Tetranychus urticae: A predator-prey perspective. Crop Protection 2017, vol. 103, p.56-64.
KABÍČEK, J. Maple Trees - Host Plants for Some Phytoseiid Mites. Scientia Agriculturae Bohemica 2017, vol. 48, no. 1, p. 1-7.
FAN, Q.H., FLECHTMANN, C.H.W., DeMORAES, G.J. Annotated catalogue of Stigmaeidae (Acari: Prostigmata), with a pictorial key to genera. Zootaxa 2016, vol. 4176, no. 1, p. 1-199.
VACANTE, V. The Handbook of Mites of Economic Plants Identification, Bio-ecology and Control. Oxon: Cabi Publishing, 2016. ISBN 978-1-84593-994-6
HAVLOVÁ, L., HULA, V., NIEDOBOVÁ, J. Spiders of the vine plants in Southern Moravia. Acta Universitatis Agriculturae et Silviculturae Mendelianae Brunensis 2015, vol. 63, no. 5, p. 1471-1476.
FAN, Q.H., FLECHTMANN, C.H.W. Stigmaeidae. In CARRILLO, D., DeMORAES, G.J., PENA, J.E. (eds.) Prospects for Biological Control of Plant Feeding Mites and Other Harmful Organisms 2015, p. 185-206. (Book Chapter)
SZABO, A., PENZES, B., SIPOS, P., HEGYI, T., HAJDU, Z., MARKO, V. Pest management systems affect composition but not abundance of phytoseiid mites (Acari: Phytoseiidae) in apple orchards. Exp. Appl. Acarol. 2014, vol. 62, no. 4, p. 525-537.
TIXIER, M. S., Klaric, V., KREITER, S., Duso, C. Phytoseiid Mite Species From Croatia, With Description of a New Species of the Genus Typhlodromus (Typhlodromus). Annals of the Entomological Society of America 2010, vol. 103, no. 2, p. 165-180.
PRASLIČKA, J., BARTEKOVÁ, A., SCHLARMANNOVÁ, J., MALINA, R. Predatory mites of the Phytoseiidae family in integrated and ecological pest management systems in orchards in Slovakia. Biologia 2009, vol. 64, no. 5, p. 959-961.
PRASLIČKA, J., BARTEKOVÁ, A. Occurrence of predatory mites of the Phytoseiidae family on apple-trees in integrated and ecological orchards. Plant Protection Science 2008, vol. 44, no. 2, p. 57-60.
NICOTINA, M., CAPONE, G.C. Side effects of some fungicides on the population of kampimodromus aberrans (Oudemans) and euseius finlandicus (Oudemans) (Parasitiformes, Phytoseiidae) on grapevines in campania (South Italy). Acta Horticulturae 2007, vol. 754, p.353-360.
MATOS, C.H.C., PALLINI, A., BELLINI, L.L., DE FREITAS, R.C.P. Domácias e seu papel na defesa das plantas. [Domatia mediating plant defense.] Ciencia Rural 2006, vol. 36, no. 3, p. 1021-1026.
DE MORAES, G., J, McMURTRY, J., A, DENMARK, H., A., et al. A revised catalog of the mite family Phytoseiidae. Zootaxa. 2004, vol. 434, p. 3+.
PEREIRA, J.A., TORRES, L., ESPINHA, I., FERRAGUT, F. Contribution to the knowledge of phytoseiid mites associated with vineyards in the "Regiao Demarcada do Douro" (Porto Wine Region). Acarologia 2003, vol. 43, no. 1-2, p. 7-13
KREITER, S., TIXIER, M.-S., AUGER, P., MUCKENSTURM, N., SENTENAC, G., DOUBLET, B., WEBER, M. Phytoseiid mites of vineyards in France (Acari: Phytoseiidae) Acarologia 2000, vol. 41, no. 1-2, p. 76-96.
O'DOWD, D.J., PERNBERTON, R.W. Leaf domatia and foliar mite abundance in broadleaf decidious forest of north Asia. Am. J. Bot. 1998, vol. 85, no. 1, p. 70-78.
O'DOWD, D.J., WILLSON, M.F. Leaf domatia and the distribution and abundance of foliar mites in broadleaf decidious forest in Wisconsin. Am. Midl. Nat. 1997, vol. 137, no. 2, p. 337-348.
SABELIS, M.W. Chapter 2.1 Phytoseiidae. World Crop Pests 1996, vol. 6, Issue Eriophyoid Mites Their Biology, Natural Enemies and Control, p. 427-456.
KOSTIAINEN, T., HOY, M.A. Genetic improvement of Ambyseilus finlandicus (Acari, Phytoseiidae): laboratory selection for resistance to azinphosmethyl and dimethoate. Exp. Appl. Acarol. 1994, vol. 18, no. 8, p. 469-484.
KOSTIAINEN, T., HOY, M.A. Variability in resistance to organophosphorous insecticides in field-collected colonies of ambyseilus finlandicus (Oudemans) (Acari, Phytoseiidae). J. Appl. Entomol. 1994, vol. 117, no. 4, p. 370-379.

ZACHARDA, M. Predatory phytoseid mites (Acari: Phytoseiidae) as bioindicators of stress impact on the farmland and butresses of the farmland revival. Ekol. Bratislava. 2001, vol. 20, no. 1, p. 47-56.
HLUCHÝ, M., ACKERMAN, P., ZACHARDA, M., BAGAR, M., JETMAROVÁ, E., VANEK, G. Obrazový atlas chorob a škůdců ovocných dřevin a révy vinné. Ochrana ovocných dřevin a révy vinné v integrované produkci. Brno: Biocont Laboratory s. r. o., 1997. 428 p. ISBN 80-901874-2-1
HLUCHÝ, M. Studies on controlling the wine blister mite calepitrimerus vitis Nal. (Acari, Eriophyidae) by means of the predator mite typhlodromus pyri Scheut. (Acari, Phytoseiidae). J. Appl. Entomol. 1993, vol. 116, no. 5, p. 449-458.

back

HLUCHÝ, M., POSPÍŠIL, Z. Use of the predatory mite Typhlodromus pyri Scheuten (Acari: Phytoseiidae) for biological protection of grape vines from phytophagous mites. In DUSBÁBEK, F., BUKVA, V. (eds.) Modern Acarology, vol. 2. Prague: Academia and SPB Academic Publishing bv, The Hague, 1991, p. 655-660.

SCHAUSBERGER, P. Juvenile Survival and Development in Euseius Finlandicus, Typhlodromus Pyri and Kampimodromus Aberrans (Acari: Phytoseiidae) Feeding on Con- and Heterospecific Immatures. Exp. Appl. Acarol. 1999, vol. 23, no. 4, p. 297-307.
SCHAUSBERGER, P. Inter- and intraspecific predation on immatures by adult females in Euseius finlandicus, Typhlodromus pyri and Kampimo dromus aberrans (Acari: Phytoseiidae). Exp. Appl. Acarol. 1997, vol. 21, no. 3, p. 131-150.

HLUCHÝ, M. Studies on controlling the wine blister mite calepitrimerus vitis Nal. (Acari, Eriophyidae) by means of the predator mite typhlodromus pyri Scheut. (Acari, Phytoseiidae). J. Appl. Entomol. 1993, vol. 116, no. 5, p. 449-458.

back

HLUCHÝ, M., POSPÍŠIL, Z. Škodlivost fytofágních roztočů čeledí Eriophyidae a Tetranychidae (Acari; Tetrapodili, Prostigmata) na révě vinné. Ochr. Rostl. 1991, vol. 27, p. 273-285.

DE VILLIERS, M. Development of a pest management system for table grapes in the Hex River Valley. Doctorate Dissertation, Stellensboch University, 2006. URL

HLUCHÝ, M. Studies on controlling the wine blister mite calepitrimerus vitis Nal. (Acari, Eriophyidae) by means of the predator mite typhlodromus pyri Scheut. (Acari, Phytoseiidae). J. Appl. Entomol. 1993, vol. 116, no. 5, p. 449-458.

back

ŽIŽLAVSKÝ, J., MIKŠÍK, J., GAJDŮŠEK, S., POSPÍŠIL, Z. Průběh a variabilita složek a vlastností mléka krav v prvních 100 dnech laktace [Changes and variability of cows milk components and properties during the 1st 100 days of lactation]. Živočišná výroba. 1989, vol. 34, no. 8, p. 675-685.

KUČERA, J., HYÁNEK, J., MIKŠÍK, J., ČERMÁK, V. The influence of the season of partutition on milk performance in the Czech pied cattle. Czech J. Anim. Sci. 1999, vol. 44, no. 8, p. 343-350.
HANUŠ, O., GAJDŮŠEK, S., BEBER, K., FICNAR, J., JEDELSKÁ, R. Composition and technological properties of milk from dairy cows in the middle stage of lactation and their interrelationship. Živočišná výroba. 1995, vol. 40, no. 12, p. 555-561.

back

HOROVÁ, I., POSPÍŠIL, Z., ZELINKA, J. Semiparametric Estimation of Hazard Function for Cancer Patients. Sankhya: The Indian Journal of Statistics. 2007, vol. 69, no. 3, p. 494-513.

HOROVÁ, I., POSPÍŠIL, Z., ZELINKA, J. Hazard function for cancer patients and cancer cell dynamics. Journal of Theoretical Biology. 2009, vol. 258, no. 3, p. 437-443.
HOROVÁ, I., KOLÁČEK, J., ZELINKA, J. Kernel smoothing in MATLAB: Theory and practice of kernel smoothing. Singapore: World Scientific Publishing Co. 2012, 227 p. ISBN 978-981-4405-48-5

back

POSPÍŠIL, Z. Gompertzian hazard function. In KOVÁČOVÁ, M. (ed.) 4^th International Conference Aplimat. Bratislava: Slovak University of Technology, 2005, p. 341-346.

HOROVÁ, I., POSPÍŠIL, Z., ZELINKA, J. Hazard function for cancer patients and cancer cell dynamics. Journal of Theoretical Biology. 2009, vol. 258, no. 3, p. 437-443.

back

POSPÍŠIL, Z. Hazard function. A deterministic point of view. In HOROVÁ, I. (ed.) Summer School DATASTAT 03, Proceedings. Brno: Masaryk University, 2004, p. 315-323.

HOROVÁ, I., POSPÍŠIL, Z., ZELINKA, J. Semiparametric Estimation of Hazard Function for Cancer Patients. Sankhya: The Indian Journal of Statistics. 2007, vol. 69, no. 3, p. 494-513.

back

POSPÍŠIL, Z. Dynamic selection systems and replicator equations. ALSHARAWI, Z., CUSHING, J.M., ELAYDI, S. (eds.) Theory and Applications of Difference Equations and Discrete Dynamical Systems. ICDEA, Sultan Quaboos University, Muscat, Oman, May 26-30, 2013. Heidelberg: Springer 2014, p., 203-213.

BABENKO, S.V., SLYN'KO, V.I. Stability of solutions of one class of nonlinear dynamic equations. Nonlinear Oscilations 2011, vol. 13, no. 4, p. 439-460.

back

POSPÍŠIL, Z. Discrete Reaction-Dispersion Equation. Bohner, M, Siegmund, S., Šimon Hilscher, R., Stehlík,P. (eds.) Difference Equations and Discrete Dynamical Systems with Applications. 24th ICDEA, Dresden, Germany, May 21-25, 2018 Heidelberg: Springer 2020, p., 323-333.

ŠPALE, D., STEHLÍK, P. Stationary patterns in bistable reaction-diffusion cellular automata. Mathematical Biosciences and Engineering 2022, vol. 19, no. 6, p. 6072-6087.

back

DVOŘÁK, P., PÁLENÍK, J., TKÁČIK, M., POSPÍŠIL, Z. Langmuir probe without RF compensation. Plasma Sources and Technology 2022. vol. 31, no. 8, doi: 10.1088/1361-6595/ac83eb

SHIN, G.W., KIM, J.H., LEE, S.H., BANG, I.Y., KIM, J.H., KWON, H.T., KIM, W.J., KWON, B-C. In-situ electron density measurement in inductively coupled plasma using microwave reflectometer by Wi-Fi antenna on wafer. Plasma Sources and Technology 2023, vol. 32, no. 6, doi: 10.1088/1361-6595/ac83eb

back

POSPÍŠIL, Z. Matematické modelování dynamiky populací. In Věda a příroda - mezioborový pohled na přírodní vědy a techniku s příklonem k biotechnické - bionické problematice. Sborník příspěvků odprezentovaných na semináři Věda a příroda 20. března 2006 na Mendelově Zemědělské a Lesnické Univerzitě v Brně. Brno: Ústav nauky o dřevě, Lesnická a dřevařská fakulta MZLU, 2006, p. 30-35.

KLIMEŠ, J. Psycholog a jeho svědectví o Kristu. Praha: Portál, 2008. 312 p. ISBN 978-80-7367-451-9.

back

PAPOUŠEK, D., POSPÍŠIL, Z. Jewish Networks in the Spread of Early Christianity : A Mathematical Model of Marcionite and Lukan Christianities. Cliodynamics 2023,vol. 14, no. 1, p. 53-74.

HUNEMAN, P. Que font les humanités numériques aux sciences dites humaines? Recherches de Science Religieuse 2024, vol. 112, no. 2, p. 201--229, DOI: 10.3917/rsr.242.0201

back